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E Summary 
Two established methods, Electrochemical Impedance Spectroscopy (EIS) and extracellular 
recording, were implemented into a technology platform for non-invasive whole-cell 
biosensing. Electrical activity of cardiomyocytes and cell-substrate interaction of human ovarian 
cancer cells was monitored on electrode array chips. The performance of cells inside a 
microfluidic or closed low volume environment was investigated. Prior to the development of 
the entire microfluidic platform the two transducing methods were evaluated in single 
experiments. 
Processes as cellular attachment and detachment were monitored using EIS and single 
frequency impedance sensing. Electrodes of different size and structure were employed and 
compared for their impedance response. It was shown that small electrodes (A = 9·10-6 cm²) are 
more sensitive to cell-substrate interaction than larger ones (A = 9·10-5 cm²) and that the 
frequency used for analysis has a profound influence on the sensitivity. Data were modelled 
using a common equivalent circuit that represents a cell layer on an electrode resulting in an 
increase of the impedance magnitude by <170 % due to cell attachment. In order to demonstrate 
the potential of this method for biomedical applications, experiments related to anti-cancer 
strategies were performed. Cell detachment was induced by addition of synthetic integrin 
ligands and by hypericin mediated photodynamic therapy and monitored with impedance-based 
biosensing. 
Electrical activity of cardiomyocytes cultured on microelectrode arrays was monitored inside a 
microfluidic system. The chronotropic drug isoproterenol was applied using a robotic 
dispensing machine, and the resulting changes in spike rate and duration were compared with 
results gained by experiments with a large scale MEA chip. 
The experimental findings inspired the development of a technology platform that was finally 
evaluated by monitoring extracellular signals from myocytes in response to Isoproterenol. 
Another topic was the comparison of cell-substrate interaction monitored on various electrode 
structures. 
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1 Introduction 
Sensors are important tools to understand, to monitor, and to control processes that are beyond 
the scope of our natural sensing “equipment”, the sensitive organs of our body. The palette of 
technical sensors was extended by employing biological material as a sensitive element. A 
popular example of an early biosensor are the canary birds that accompanied British coal miners 
until the late 1980s in order to signal toxic gases, for instance the colourless, odourless, and 
tasteless carbon monoxide.  
Biosensors are devices with biological material coupled to common sensor elements that 
transduce the response of the biologic element into measurable data. Particularly, cells have a 
high organisational complexity compared to anything encountered in the non-living world, as is 
exemplified by the presence of numerous internal compartments and specialised membranes. 
These specialisations serve to generate gradients of diffusible substances, enable transport of 
specific molecules, and coordinate enzymatic reactions [Goldsmith 2001].  
Parallel to this structural complexity, cells are also specialised for different functions and are, 
for instance, able to detect analytes with higher specificity and sensitivity than human-made 
sensors can do. Hence, the transfer of these properties from in vivo to in vitro systems is a 
rational methodology for constructing ‘new generation’ biosensors with high sensitivity and 
selectivity. Whereas molecular assays are quite common in pharmaceutical research, using 
whole cells is comparably rare. Whole cell biosensing is mostly performed using optical 
detection methods involving specific labelling by fluorescent protein species or by nanobeads. 
These methods may interfere with cellular pathways. Therefore, research on methods that non-
invasively investigate responses of a complete cell is of great interest, in particular as cells can 
be manipulated by genetic engineering to sense for a defined target [Aravanis 2001]. But, 
research has to aim at the presentation of reliable and reproducible assay formats as required by 
pharmaceutical industry. 
A long-term perspective is the application of whole cell biosensing as a validated alternative for 
animal trials. The need of such alternative methods to at least reduce animal testing becomes 
clear after implementing the new European chemicals law – REACH; Registration, Evaluation 
and Authorisation of Chemicals. About 30,000 of the 103,000 notified chemical substances 
[ECVAM 2004] have to be analysed involving the usage of about 12.8 x 106 vertebrates and the 
amount of 6.51 x 109 € according to cautious estimations [IEH 2001]. The application of 
alternative in vitro testing methods for various kinds of toxicity are therefore of growing 
interest, although this will only help to reduce animal trials but will never substitute them. 
Aiming at the commercial goal of reproducibility and reliability, this thesis focused on 
automation of cell-based sensing. The prototypic biosensing system developed consisted of a 
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computer controlled test substance dispenser, a user friendly sensor design, and a microchannel 
supplying cells with culture medium and test substances. The microchannel incorporated into a 
microfluidic unit and allowed continuous nutrient supply to cells and access of test substances at 
low dead volumes offering short sample/rinse cycles. This approach involved the culture and 
isolation of electrogenic cells, heart muscle cells from rat embryos, on planar electrode array 
biosensors. Their electrical activity was non-invasively sensed by extracellular recording 
revealing the cellular sensitivity to pharmacologically or toxicologically active agents. 
In a second approach non-electrically active cells, i.e. human tumour cells were investigated 
using a different electrical transducing method, i.e. Electrochemical Impedance Spectroscopy. 
Tumour cells are characterised by robust cell infiltration mechanisms allowing to invade other 
tissues. Microscopic methods are applied to reveal whether a certain substance affects the cell-
substrate interaction or not. Assays that transduce this interaction into physical parameters and 
allow to monitor tumour cell adhesion in real-time are useful for the to optimisation of cancer 
therapies, as shown for photodynamic therapy.  
The results of these studies and the operation of the prototype microfluidic system led to the 
development of a second microfluidic technology platform that combined optical microscopy, 
impedance analysis, and extracellular recording. 
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2 FundamentalsEquation Chapter 2 Section 1 
2.1 Cell Biology 
2.1.1 Cell Adhesion 
Cell-substrate interaction is of interest in biophysical and biomedical research. Cell adhesion 
provides important signals in cellular development and is responsible for several processes in 
tissue structure, tissue remodelling, and wound healing. Abnormalities in adhesion often 
indicate pathological conditions as cancer metastases or intravenous blood coagulation. 
Adhesion of cells to extracellular structures requires a mixture of various multiadhesive or 
adhesion promoting proteins adsorbed to the substrate – the so-called extracellular matrix 
(ECM). This cell-protein adhesion is central to the design of compatible biomaterials and in 
tissue engineering [Gallant 2002].  
A generalised scheme of cells attached to a solid support is given in Figure 2-1. Cell-adhesion 
molecules recognise specific multiadhesive proteins (or adhesion promoting proteins) and form 
cell-matrix adhesions. For instance, integrins as membrane spanning cell adhesion molecules 
bind to extracellular proteins like fibronectin or laminin. Cadherins are responsible for cell-cell 
adhesions. Adhesion triggers an intracellular signal originating from the cell adhesion 
molecules. Bound receptors rapidly associate with intracellular attachment proteins that 
promote fast assembly of the cytoskeleton. This was found to be a highly regulated, two-stage 
process involving initial receptor-ligand interaction and subsequent adhesion strengthening and 
cell spreading. After the cytoskeleton assembly has been terminated, cells have transformed 
from spherical to stiff, irregularly shaped objects. 
Later, lamellipodia develop focal adhesions that can further support robust cell adhesion 
[Gallant 2002, Small 2005]. They are composed of cytoskeleton proteins that prominently 
Figure 2-1: Cells adhering to a 
substrate. Cell-matrix adhesions 
are formed by cell-adhesion 
molecules that bind to 
multiadhesive proteins 
adsorbed onto the surface 
[Lodish 1996]. A cell-substrate 
gap of ~150 nm thickness is 
formed [Zeck 2003]. 
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appear as pioneering structures on the leading edge of the cell, and prevent withdrawal of the 
newly attached membrane during cellular motion. Therefore, focal adhesions are key elements 
in the adhesion process, because they are structural links between the cytoskeleton and the ECM 
and trigger signal pathways that control cell proliferation and differentiation. Furthermore, they 
play a central role in cell migration.  
However, this layer-by-layer arrangement of extracellular protein and cell membrane leads to a 
measurable gap between the basal membrane and the support. This cell-substrate or basal gap 
can be characterised by Fluorescence Interference Contrast Microscopy and was found to be in 
the range of 150 nm [Zeck 2003]. 
Multiadhesive Proteins 
The affinity of a protein to a biomaterials surface can be characterised by an adsorption 
constant, which is an indirect measure of the non-covalent bond at the surface. Two models 
have been used to quantify equilibrium protein adsorption data, the Langmuir and Freundlich 
adsorption isotherms [Young 1988]. Adsorption is dependent on surface charge and 
hydrophobicity of the substrate, on ion strength and pH value of the electrolyte, and on 
properties of the proteins. 
Cell-matrix adhesions require specific interaction of proteins with membrane receptors. The 
tertiary structure of the protein is responsible for correct recognition. A slight change in 
conformation can cause steric repulsion leading to prevention of cellular adhesion. Protein 
conformation is also influenced by surface charge of the material the protein is adsorbed to as 
immunostaining revealed [Keselowsky 2003].  
The binding sites that are responsible for cell-protein interaction usually contain the amino acid 
sequence Arginine-Glycine-Aspartate (RGD). This sequence binds to integrins and therefore 
forms an important cell adhesive motif present in some ECM proteins as collagen, fibronectin, 
laminin, and vitronectin [Ruoslahti 1987]. The identification of this major binding site offered 
new perspectives in biological surface science. For instance, a number of integrin ligands were 
synthesised on the basis of the RGD sequence partly resulting in higher affinities than naturally 
occurring ligands [Thumbshirn 2003] useful in tumour diagnostics and therapy (see Chapter 
2.1.3). 
 
2  Fundamentals  17 
  
2.1.2 Electrogenic Activity of Cardiomyocytes 
Normally, the cell membrane of any cell is polarised because of an unequal distribution of ion 
species between the cell’s interior and the extracellular environment. Cells that are able to de- 
and repolarise the membrane are characterised by electrogenic activity. For instance, these cells 
can generate an action potential by ion transfer across the membrane. Cells of the nerve system 
and muscle cells belong to this type. In the case of rhythmic contraction of e.g. heart muscle 
cells, the action potential is triggered by pacemaker cells that provide a specific set of ion 
channels allowing for rhythmic changes of the membrane potential. 
The cardiac action potential has a duration of approximately 300-400 ms [Walker 1998] and 
remains depolarised for longer time periods, compared to other electrogenic cells. During the 
course of an action potential, the resting potential of a cell is altered by opening of ion channels 
that permit the flux of ions across the membrane. A typical action potential is given in Figure 
2-2. It displays different phases that result from a sequence of ion currents. 
 
 
 
 
 
Phase 0 corresponds to a fast membrane depolarisation. The onset of the action potential is due 
to an instantaneous increase in membrane permeability to Na+ ions and a concomitant decrease 
in K+ permeability. Once the enhanced flux of Na+ ions across the membrane is lowered, a slight 
repolarisation occurs (phase 1). The membrane depolarisation causes an opening of voltage-
gated Ca2+ channels that mediate an intense influx of Ca2+, which antagonises the loss of K+ 
ions. This results in a steady potential of about zero millivolts (so-called plateau; phase 2) and is 
the basis for the prolonged duration of the cardiac action potential. Moreover, the Ca2+ influx 
provides the high intracellular Ca2+ concentration essential to the contractile performance of 
myocytes. After closure of Ca2+ channels and increased K+ permeability, the membrane 
potential repolarises (phase 3) to a negative resting level of about -60 mV (phase 4) until the 
next action potential is generated.  
Figure 2-2: Cardiac action potential. The course 
is characterised by several phases (details see 
text). Its total amplitude is in the range of 30 to 
100 mV at a duration of 300 to 400 ms.  
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The Hodgkin-Huxley theory [Hodgkin 1952] allows one to simulate the course of an action 
potential. The ion conductance gi of a single ion species is determined by the ion flow density 
iM, the membrane potential VM, and the Nernst potential E according to 
 Mi
M i
ig
V E
= − . (2-1) 
The Nernst potential E is the equilibrium potential of a model membrane that is only permeable 
for a single ion species and is described as 
 ln
in
i in out out
cRTE E E
zF c
= − =  (2-2) 
where R is the gas constant, T the temperature, z the valence of the specific ion, F the Faraday 
constant, and c the concentration of the specific ion inside (in) and outside (out) the cell. 
The Hodgkin-Huxley model for the cell membrane is displayed in Figure 2-3. Ion species 
specific conductances gi and Nernst potentials Ei are considered in parallel to the specific 
membrane capacitance cM. Leak currents are summed up in the voltage-dependent leakage 
conductance gL, and ion concentrations are given by an equilibrium potential EL. The ion 
concentration is affected by the activity of the Na+/K+ pump and the Na+/Ca2+ exchanger (active 
transporters). 
 
 
 
 
 
 
 
 
 
 
Figure 2-3: Hodgkin-Huxley model. The equivalent circuit describes the electrical properties of a cardiac cell 
according to [Hodgkin 1952]. Ion species involved contribute to the membrane potential by their Nernst potentials 
Ei and the specific ion conductances gi. Index L refers to an overall leakage current. Moreover, membrane 
capacitance and active transporters contribute to the membrane potential. 
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As shown in Figure 2-3, not only a single ion species contributes to the membrane potential. To 
consider K+, Ca2+, and Na+ fluxes, a permeability coefficient P was defined leading to the 
definition of the Goldman equation. The coefficient P is a measure for the permeability of a 
1 cm² large membrane patch for a certain ion species with a concentration gradient of 1 mol 
across the membrane. Permeability is proportional to the number of open ion channels and to 
the number of ions that can pass a single channel in 1 s. The membrane potential across a 
plasma membrane can be calculated by an “extended” Nernst equation that weighs the ion 
concentrations according to the specific permeability coefficients. Ion concentrations are 
indexed “i ” for intracellular values and “o” for values outside the cell.  
 
 
2
2
2
2
ln K Na Cao o im
K Na Cai i o
P K P Na P CaRTE
F P K P Na P Ca
+ + +
+ + +
+ + +
+ + +
     + +     =      + +     
 (2-3) 
 
The Goldman equation can be used to calculate the membrane potential for known ion 
concentrations and ion permeabilities.  
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2.1.3 Tumour Cells 
In tumour biology, cell adhesion is of interest because tumour invasion into the surrounding 
tissue and metastasis require fine tuning of adhesive contacts. Expression of ECM components 
and integrins is frequently modulated in response to changes within the tumour cell vicinity 
during tumour cell progression [Hapke 2001]. Tumour growth, for example, stimulates 
surrounding endothelial cells by release of growth factors to build up blood vessels in a process 
that is called angioneogenesis. Because cancer cells have a high oxygen demand, additional 
blood vessels are necessary for tumours that exceed a certain size (~3 mm³). The activated 
endothelial cells often over-express the integrin receptor αvβ3, which serves as an indicator for 
the invasive phase of tumour cells [Thumbshirn 2003]. 
Integrin-Ligand Induced Tumour Cell Detachment 
Following this idea, passivation of the αvβ3 integrin by binding to a tailor-made ligand is a 
promising approach in tumour therapy [Thumbshirn 2003]. Because the peptide sequence RGD 
was identified as the minimal fragment for stimulation of cell adhesion, it was the basis for 
further synthesis of peptide and non-peptide ligands. For example, the insertion of D-amino 
acids resulted in the synthetic αvβ3 selective ligand cyclo(-Arg-Gly-Asp-D-Phe-Val-) or 
c(-RGDfV-) [Thumbshirn 2003], which exhibits a higher affinity to the integrin receptors than 
adhesion promoting proteins. Using water soluble peptides the tumour induced angioneogenesis 
can be suppressed, because ECM molecules are less attractive to the receptors, and the cell on 
binding to the artificial ligand, loses contact to the surface. Consequently, reorganisation of the 
cytoskeleton takes place causing detachment of the cell from the substrate and induction of 
programmed cell death (apoptosis). By following this approach, proliferation (metastasis) was at 
least successfully hindered for cells that over-express αvβ3 integrins [Thumbshirn 2003]. 
However, before this strategy can be clinically investigated, promising substances need to be 
screened for their functionality. This is mainly done by culturing cells in culture flasks and 
visual observation of the cellular detachment in response to administered substances [Hapke 
2003]. In contrast, biosensors capable of directly monitoring detachment have a great potential 
to perform this and other screening tasks more efficiently. Cell adhesion and cell spreading, for 
example, was investigated on quartz crystal microbalances [Li 2005]. In this study, a human 
ovarian cancer cell line (OV-MZ-6) was used as a model system for cell-substrate interaction. 
The same cell line was also subject to research on cellular adhesion [Hapke 2001] and is used as 
a model in this thesis, too.  
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Photodynamic Therapy 
Photodynamic therapy (PDT) is a cancer therapy, that is – in contrast to the previously 
presented drug targeted approach - already approved by several countries although strong side-
effects are apparent. In the late 19th century modern light therapy began, as the Danish Niels 
Finsen used UV light to treat cutanous tuberculosis and was awarded the Nobel Prize for his 
discoveries in 1903. But, ancient Egyptian, Indian, and Chinese civilizations used light to treat 
various diseases (as psoriasis, rickets, vitiligo and skin cancer). Nowadays, research aiming at 
optimising the technique and agents used is still highly promising. Photodynamic therapy has 
been used to treat cancers of the brain, lung, pancreas, intraperitoneal cavity, breast, prostate 
and skin [Dolmans 2003]. 
The therapy involves the administration of a photosensitiser into tumour tissue by local 
injection. Photosensitisers are able to absorb light because they are aromatic compounds 
carrying a large number of conjugated π-electrons. The therapy is continued by local irradiation 
leading to photoactivation of the sensitiser. Lasers, fluorescent lamps, or other light sources are 
applied at a wavelength matching its absorption spectrum. The activated substance produces 
reactive oxygen species (ROS) from tissue oxygen. Reactive oxygen species, in turn, kill 
tumours or destroy tumour-associated vasculature. Reactive oxygen species are characterised by 
a short half-life and damage only cells that are proximal to the area of the ROS production. For 
instance, the action radius of the highly reactive singlet oxygen is below 0.02 µm [Dolmans 
2003]. Photodynamic therapy also evokes a tumour cell specific immune response to some 
extent. Cytotoxicity caused by PDT is limited to the area of photosensitiser localisation. If the 
tissue is not directly accessible to irradiation, a cylindrical fiberoptic is used to guide the light 
into the tumour. 
The extent of photodamage and cytotoxicity is multifactorial. It depends on the type of 
sensitiser used (localisation, dose administered), the parameters of irradiation (light exposure 
dose, light fluence rate), the type of tissue (oxygen availability), and the interval between drug 
administration and light exposure [Dolmans 2003]. 
Haematoporphyrin derivatives are widely used as photosensitisers. The standard clinical 
sensitiser, Photofrin®, includes several of these compounds. Although Photofrin® was proven 
efficient, a number of drawbacks underpin the need of further research for an alternative 
substance: Its ingredients are poorly defined, its persistence in the body results in long-term skin 
photosensitisation, and the molar absorption coefficient is low. 
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The Photosensitiser Hypericin 
A promising alternative is hypericin. This polycyclic dione is found in Hypericum plants (St. 
John’s wort) and is most sensitive to light of 595 nm wavelength. It preferentially accumulates 
in the membranes of the endoplasmic reticulum and Golgi apparatus and mediates apoptosis by 
a number of biochemical pathways upon photoactivation. It is barely cytotoxic in the dark. 
 
 
 
 
 
 
 
Molecular biological research on biochemical pathways that lead to hypericin induced apoptosis 
was performed by Hendrickx and co-workers [Hendrickx 2003]. They suggested a possible 
improvement of the therapeutic efficacy by combination of photodynamic therapy with 
pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase (MAPK). The kinase 
may also be activated by photodynamic therapy, which in turn triggers angiogenesis and cell 
growth due to up-regulation of the gene that codes for cyclooxogenase-2 (COX-2). In vivo data 
on photodynamic therapy with Photofrin® revealed that COX-2 inhibition contributes to 
increased anticancer activity mainly by reducing the release of growth promoting factors, which 
otherwise may support tumour re-growth and neo-vascularisation after photodynamic therapy 
[Ferrario 2002, Hendrickx 2003, Makowski 2003]. 
A standard method to determine the effect of PDT is a common cell viability assay. The dye 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) is supplied to the cell 
culture and subsequently reduced by mitochondrial dehydrogenases of viable cells. The 
resulting product formazan is of blue colour and can be quantified photometrically. Hence, poor 
conversion of the yellowish MTT solution into blue formazan indicates cell impairment.  
Several in vitro approaches were reported for PDT using hypericin [Paba 2001, Hendrickx 
2003, Martinez-Poveda 2005]. Various excitation systems with and without filter systems were 
applied, as fluorescent lamps, argon lasers, and halogen lamps. Fluence rates ranged from 0.002 
to 12 W/cm², exposure doses from 4 to 16 J/cm² or 120 J/cm² for an in vivo approach [Du 2003]. 
Hypericin was administered at concentrations from 1 to 1000 nM at incubation periods of 16 to 
Figure 2-4: Structure of hypericin 
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48 hours. As these parameters need to be individually adapted to the respective cell culture, the 
importance of a real-time monitoring system becomes obvious. 
2.2 Cell-Based Biosensing 
A biosensor is a solid-state sensor that carries biologically derived molecules on its sensor 
surface [Kovacs 1998, Ziegler 2000]. The biological material is the sensitive element of the 
device and acts as a primary transducer, corresponding to a secondary transducer that generates 
signals that can be monitored and processed. In the case of cell-based biosensors, whole cells 
are cultured on the sensor surface as primary transducer. Cell features as metabolic activity, 
selectivity of interactions, and electrogenic activity offer new perspectives in cell-based 
biosensing [Bousse 1996]. Because living cells require finely tuned physiological conditions, 
such sensing systems are not always robust and also require sample conditioning.  
2.2.1 Impedance Analysis 
Interpretation of cellular signals in cell-based biosensing is performed by a secondary 
transducing method, for instance electrochemical impedance spectroscopy (EIS). 
Impedance Spectroscopy 
Impedance Spectroscopy is a powerful method for characterising electrical properties of 
materials and their interfaces with electrically conducting electrodes. Generally, an electrical 
voltage (stimulus signal) is applied to the electrodes, and the resulting current passing through 
the solid or liquid sample is measured as response. The overall response is composed of many 
processes that are mainly the transport of electrons or charged ions through the bulk sample and 
its interfaces. Hence, the flow profile (or current response) reflects structural properties of the 
sample.  
Different kinds of stimuli are applicable [Barsoukov 2005]. For instance, a step function is 
easily accomplished, but associated with the integral transformation of the time-varying current. 
Random white noise records the whole response over a wide spectrum instantly, but requires 
true white noise [Wiegand 2003]. In the most common method, a small-amplitude AC signal is 
applied that sweeps over a wide range from milli- to megahertz frequencies. 
There are many fields of application, as quality control of paints and emulsions, electroplating, 
thin-film technology, corrosion, but also investigation of biological issues as biological 
membranes. 
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Impedance Theory 
The response to a sinusoidal small-signal voltage v(t) with the frequency ω and the amplitude 
Vm  
 ( ) sin( )mv t V tω=  (2-4) 
is the current  
 ( ) sin( )mi t I tω θ= + . (2-5) 
The phase difference θ  between the voltage and the current of the investigated system is zero 
for purely resistive systems, + 90° for an inductance L, and – 90° for a capacitance C. The 
response of a capacitor C and an inductance L is given by the equations  
 
( )( )C
dv ti t C
dt
=  (2-6) 
and  
 
( )( )L
di tv t L
dt
=  (2-7) 
In order to introduce the complex impedance, the two differential equations can be transformed 
into the complex domain  
 ( ) ( )I j C j V jω ω ω=  (2-8) 
and  
 
( )( ) V jI j
L j
ωω ω=  (2-9) 
with  
 1j ≡ − .  (2-10) 
The relation between the frequency domain voltage and current is now given by the complex 
impedance (analogous to Ohm’s law for DC voltages) 
 
 
( )( )
( )
V jZ j
I j
ωω ω= . (2-11) 
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This complex impedance function ( )Z jω , or simply ( )Z ω , can be interpreted as a vector in 
the right-hand orthogonal system, as illustrated in Figure 2-5:  
 ( )Z Z jZω ′ ′′= +  (2-12) 
with the real part  
 { }Re cos( )Z Z Z θ′≡ =  (2-13) 
and the imaginary part 
 { }Im sin( )Z Z Z θ′′≡ = . (2-14) 
In the complex plane the vector is characterised by the phase angle  
 1tan Z
Z
θ − ′′ =  ′   (2-15) 
and the modulus  
 ( ) ( )2 2Z Z Z′ ′′= + . (2-16) 
The arrow tip moves along a curve for varying frequencies, because impedance is frequency 
dependent (except for ideal resistors). 
 
 
 
 
 
 
 
 
 
Figure 2-5: Impedance displayed in the complex plane. After [Barsoukov 2005]. 
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Impedance Data Acquisition and Analysis 
To determine impedances technically, the sample is connected to at least two probing electrodes 
and the impedance value is computed from the stimulation signal and the response. Real and 
imaginary parts are acquired and stored. Impedance magnitude and phase are derived by 
equations (2-15) and (2-16) for each frequency point.  
Electrical properties of the investigated system are finally modelled from experimental data. 
Therefore, a so-called equivalent circuit is developed for the specific situation that describes the 
investigated system as a network of impedances. Structures that hinder current flow are 
represented by resistors, those that accumulate charge by capacitors, those that induce current as 
inductors. The circuit is then improved by a repeated modelling process. 
In Figure 2-6 an example equivalent circuit is shown that was simulated in the frequency 
domain (A) and in the complex domain (B to D). Impedance magnitude and impedance phase 
are displayed in Bode diagrams which is advantageous for an initial survey covering a wide 
frequency range (Figure 2-6 B+C). Impedance imaginary part over real part is displayed in the 
Nyquist plot that focuses on low frequency data (Figure 2-6 D). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-6: Impedance simulation of a sample circuit. (A) Equivalent circuit with R1 = 1 kΩ, R2 = 10 kΩ, C2 = 10 nF, 
R3 = 50 kΩ, and C3 = 1 µF. (B, C) Bode diagrams with impedance magnitude and impedance phase over frequency. 
(D) Nyquist plot with negative imaginary part of real part over impedance Z. Apex frequencies ω1 and ω2 allow an 
estimation of the capacitance C of the RC element, according to equation (2-17). 
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Information on the components contributing to the system response can be derived from both 
kinds of representations. The slope m of the curve of Figure 2-6 B refers to resistive (m = 0), 
capacitive (m < 0), or inductive (m > 0) influences. Impedance magnitude at 1 mHz equals the 
sum of R1, R2, and R3 because C2 and C3 block currents at low frequencies. Magnitude at 
1 MHz equals to R1, because the current by-passes R2 and R3 via capacitances C1 and C2 in 
this case. The phase plot (Figure 2-6 C) also indicates capacitive, resistive, and inductive 
influences correlating to the magnitude plot. Impedance phase, as the divergence of current and 
voltage signal, is shown in degrees. For purely capacitive behaviour, the current is out of phase 
by +90°. In the Nyquist plot (Figure 2-6 D), resistances can be derived from the distance of 
semi-circles from the origin and the diameters of semi-circles. A semi-circle represents a RC 
combination in parallel. The frequency ω at the apex of a semicircle equals to  
 
1
RC
ω = , (2-17) 
which can be used to estimate the capacitance C [Hamann 1985]. 
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Cell Impedance Sensing  
Impedance analysis is not restricted to electrochemical measurements monitoring anode and 
cathode processes in an electrolyte, but can also be applied to biology. The most prominent 
application in this field might be the determination of body fat with bio-impedance analysis. 
Here, impedance analysis of the human body connected to electrodes elicit information on water 
content and ratio of muscle/fat tissue due to different response characteristics to the stimulating 
signal. 
Cells can also be investigated by EIS in vitro to analyse metabolic activity or cell-substrate 
interaction. This cell impedance sensing is performed either on cells that are suspended in 
culture medium or on cells cultured directly onto a sensor. Adherent or cultured cells are sensed 
on a single electrode against a (distant) counter electrode. In Figure 2-7 A, cells are shown that 
cover an electrode of 250 µm in diameter on a commercially available impedance sensing 
system (Applied Biophysics, Troy, USA) that is described in detail below. The cultivation of 
single cells on so called microelectrodes of diameters down to 5 µm (Figure 2-7 B) is less 
common. Another type of electrode is the interdigitated electrode that comprises both 
electrodes, working and counter electrode, as finger-like structures next to each other (Figure 
2-7 C).  
 
 
 
 
 
 
 
Impedance sensing of cells at a fixed frequency with phase-sensitive detection was first 
described in 1984 as electrical cell impedance sensing (ECIS) [Giaever 1984]. Lung fibroblasts 
were cultured on electrically wired Petri dishes, and an AC voltage was applied to a single 
sensing electrode integrated in the dish. The resulting voltage was measured using a lock-in 
amplifier. 
Figure 2-7: Cell Impedance Sensing. (A) Confluent cell monolayer on a large circular electrode [Wegener 2006]. The 
rim around the electrode indicates the electrode boundary. (B) Schematic drawing of a single cell, placed on an 
electrode. (C) Interdigitated electrode composed of three fingers each. Black electrode areas are insulated whereas 
grey areas represent the activate electrode area. 
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Giaever and Keese developed a commercially available measurement system for Electric Cell-
Substrate Impedance Sensing (Figure 2-8). It was communicated as a cell morphology biosensor 
using planar gold electrodes and was employed for the determination of micromotion, 
metastasis activity, and adhesion processes as well as for wound-healing assays [Giaever 1991, 
Lo 1995]. 
 
  
 
Figure 2-8: ECIS™ sensor device. (A) Loading of the 8-well sensor. (B) Closer image on culture wells and 
(C) on an integrated electrode. Each well is equipped with an electrode of 250 µm in diameter and a large 
counter electrode (black stripe along the centre) [Applied Biophysics 2004]. 
A B 
C 
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2.2.2 Cell-Substrate Modelling for Impedance Analysis 
The impedance change of a cell layer located on a metal microelectrode in response to a 
sinusoidal signal is determined by a number of elements as wires, the electrode-electrolyte 
interface, the electrolyte with non-adherent cells in suspension, and the adherent cells. In 
addition, one has to take into account that the cell layer is very heterogeneous. For instance, 
partial coverage and the quality of the sealing between cells (gaps and junctions) influence the 
system response. Moreover, the composition of the cell membranes loaded with different pores, 
ion channels, and transporters strongly define electrical characteristics. But also the effect of the 
cell’s interior consisting of an aqueous cytosol and membrane-equipped organelles have to be 
considered. Below, these elements are addressed in detail with respect to their contribution to 
impedance measurement results. 
Wires and Connectors 
Whereas the resistance of wires is low and therefore negligible, stray capacitance and stray 
inductance of wires has a higher relevance for modelling cell-substrate interaction. Stray 
capacitance can affect the accuracy of the measurement particularly at low frequencies and for 
high impedance samples. In contrast, stray inductance is mostly discernible for low impedance 
samples at high frequencies [Bio-Logic 2007]. 
Electrolyte 
The resistive component of this impedance is given by  
 electrolyte
sR
Aκ=  (2-18) 
with length s of the current path, area A, and electrolytic conductivity κ. Usually, the impedance 
of the cell culture medium is below 100 Ω and therefore negligible.  
Electrode-Electrolyte Interface 
Various models of charge distribution at the electrode-electrolyte interface and its spatial 
arrangement were published. The recent model of the electrical double layer is based on the 
work of Helmholtz published in 1879 [Geddes 1972]. According to Helmholtz, a double layer 
manifests as ions tightly bind to the electrode surface, and a counter-layer of oppositely charged 
ions builds up in the solution (Figure 2-9 A). In 1910, Gouy proposed an arrangement of a 
diffuse and a fixed layer taking thermal motion of ions into account (Figure 2-9 B). In 1924, 
Stern added the possibility that the negative charge in the fixed layer could overbalance the 
positive charge of the electrode (Figure 2-9 C). Another modification of the model was 
performed by Gouy, who introduced an exclusively diffuse layer (Figure 2-9 D). Following this 
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model, charge separation induces a linear potential drop close to the electrode, bordered by the 
inner Helmholtz plane. Then, the potential declines exponentially with distance from the 
electrode. The actual charge distribution depends on the type of metal and electrolyte used. 
However, non-ideal metal electrodes are not sufficiently described by a capacitive electrode-
electrolyte coupling. Due to electrochemical reactions on the surface some charge leaks across 
the interface (faradaic currents) experiencing a charge transfer resistance and a Warburg 
impedance (Figure 2-9 E). The latter is related to diffusion of ions from the bulk electrolyte to 
the interface [Ehret 1997]. 
 
 
  
Figure 2-9: Electrode-electrolyte interface. (A) - (D) Sketches of electrochemical double layers after [Geddes 
1972]. Charge distribution at the electrode interface region is shown as (+) and (-) and as a potential ψ over 
distance x. The distance δ  indicates the Helmholtz plane. (E) Electrochemical equivalent circuit for a metal 
electrode submersed in electrolyte with RS resistance of the solution, Cdl the double layer capacitance, Rct the 
charge transfer resistance, and ZW the Warburg impedance [Ehret 1997]. 
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Interface Impedance Modelled by the Constant Phase Element 
Experiments reveal that the model presented in Figure 2-9 E do not accurately fit data of typical 
electrodes used in impedance analysis. Indeed, it was only found to be a suitable description 
when perfectly smooth mercury electrodes are used [McAdams 1995]. A comparison of the 
circuit simulation and real data of a rough surfaced Ag/AgCl ink electrode is given in Figure 
2-10. The Nyquist plot format was chosen to focus on high frequency data where the impedance 
behaviour differs most.  
Many attempts have been performed before to describe the impedance of rough metal-
electrolyte interfaces, but failed to model the system correctly because too many variables were 
used, or assumptions were questionable. 
Then, real impedance data was modelled more accurately by an empirically developed element 
that lacks a physical background which brought up controversial discussions. The constant 
phase element (CPE), also described as constant phase angle or distributed circuit element, was 
first applied in 1984 by Van den Eeden [McAdams 1995] as a model for electrode surfaces. The 
term constant phase refers to the angle φ of the impedance locus against the Z’ axis in the 
Nyquist plot, as illustrated in Figure 2-5. This constant phase angle impedance was often 
observed on solid metal electrodes over a limited frequency range and was, most likely, referred 
to surface roughness effects. 
The empirical equation for the CPE is given as 
 ( )IZ K j βω −= , (2-19) 
where K is a measure of the magnitude of ZI, and β a fractional power constant related to the 
grade of surface roughness with 0 < β < 1. A value of 1 equals to a perfectly smooth surface. β 
is associated with the phase angle by  
 / 2φ βπ=  (2-20) 
or  
 90φ β= °  (2-21) 
[McAdams 1995, Fricke 1932]. 
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Figure 2-10: Impedance locus for Warburg impedances; according to Figure 2-9 E. (A) Simulation result of the 
equivalent circuit (inset) for an ideal, smooth electrode. (B) Impedance result of a real-world porous electrode. Both 
diagrams after [McAdams 1995]. 
Figure 2-11: Constant phase element in 
the complex plane. CPE impedance 
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The empirical description of the rough surface by the CPE finally received support from 
Mandelbrot’s work on fractal geometry [Mandelbrot 1983]. According to the fractal concept, a 
single parameter, the fractal dimension D, is capable of characterising a rough surface without 
the need of a detailed description. Using these concepts the following expression was derived 
[Nyikos 1985]:  
 ( )I total SZ R A Z β= +  (2-22) 
where ZS is the anticipated interface impedance in the absence of surface effects, β is a 
fractional power (0.5 < β < 1) related to the fractal dimension of the electrode surface, A is a 
proportionality constant which contains all frequency-independent factors, and Rtotal is the 
resistive influence of the electrolyte and leads. At high frequencies ZI is dominated by Cdl and 
therefore equation (2-22) approximates to  
 ( )I totalZ R K j βω −= +  (2-23) 
where  
 ( )DLK A C β−=  (2-24) 
[Nyikos 1985]. 
Homogenous Layers on an Electrode 
In impedance analysis, coatings are often modelled as RC elements, composed of a capacitance 
and a resistance in parallel. The capacitance C comprises dielectric properties of coating 
material and electrolyte, the distance, and the sensing area. The resistance R is a measure of 
sealing quality. These RC elements are characterised by a time constant τ with 
 RCτ = , (2-25) 
where the time constant τ is related to the frequency domain by  
 1f τ −= . (2-26) 
The influence of slight changes of the RC element components is shown in Figure 2-12. Three 
circuits are simulated over a frequency range from 1 Hz to 10 GHz. The electrode is simplified 
in all cases to a 1 nF capacitor C, and the coating capacitances C1 and C2 are both set to 100 pF. 
Only the coating resistors R1 and R2 are varied. Simulations in a Bode plot (Figure 2-12 A+B) 
illustrate that RC elements are reflected as impedance phase maxima. Analysing two RC 
elements in series (red line) reveals that the RC element with the larger time constant clearly 
dominates over the smaller one. 
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Figure 2-12: Impedance analysis of RC elements. (A) Magnitude plots and (B) phase plots of a (C) simulation 
circuit. 
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Confluent Cells on Electrodes 
Another type of coating with very heterogeneous properties is represented by biological cells, 
that adhere as a tight layer to the electrode. This confluent cell layer also blocks currents and 
cause an increased electrode impedance [Schwan 1963]. 
A schematic illustration of a group of cells attached to a microelectrode is shown in Figure 
2-13 A. The counter electrode is integrated into the sensor surface and therefore currents must 
not necessarily pass the confluent cell layer. Thus, the cell/substrate gap can also permit currents 
beneath the cell layer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-13: Confluent cells on a microelectrode. (A) Schematic illustration with cells on a microelectrode (black) 
and insulation layer (dark grey) on glass substrate (light grey). Arrows show possible current path between working 
and counter electrode. (B) Equivalent circuit of current path that enter the sensor surface through the electrode on the 
right. Three current path refer to the arrows of part (A). R1 to R3 consider electrolyte resistances. (C) Circuit used 
for simulation of the neuron-electrode contact [Buitenweg 1998]. (D) Simplified equivalent circuit for modelling 
impedance data. 
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A variety of current pathways between electrode and counter electrode are imaginable focusing 
on analysis. Some are depicted as arrows in Figure 2-13 A. Currents may pass through the cells 
across the basal and the apical cell membranes, through the junction between two cells, or may 
bypass cells via the cell/substrate gap between sensor insulation and basal cell membranes. 
This situation leads to the equivalent circuit presented in Figure 2-13 B. The electrode 
impedance is modelled as a CPE. Miscellaneous resistances of e.g. the electrolyte or adsorbed 
protein layers are recognised as resistances R1 to R3 specifically for each branch although they 
are presumably small against membrane or sealing resistance. The sealing quality of the cell 
layer is represented by the resistance Rsealing depicted in the bottom branch. 
A simulation of a neuron on small gold electrode was developed by [Buitenweg 1998], shown 
in Figure 2-13 C. Cell membranes are considered as single RC elements (indices mem and 
patch). Moreover, a shunt capacitance counts for the capacitive coupling of the lead structures 
and the culture medium. The total impedance was defined as  
 sh CEtotal
sh CE
Z ZZ
Z Z
= +  (2-27) 
with  
 
1
sh
sh
Z
i Cω= . (2-28) 
and  
 
( )seal mem patch
CE electrode
seal mem patch
R Z Z
Z Z
R Z Z
+= + + + . (2-29) 
Where index CE stands for the cell-electrode interface. Again, this is a model for simulation 
purposes, but not suitable for modelling real-world impedance data.  
In summary, the physical situation of a cell layer covering an electrode is a complicated mesh of 
resistive and capacitive reactances. This needs to be simplified for successful, accurate 
impedance data modelling to a simplified representation as shown in Figure 2-13 D. A similar 
model with an additional electrolyte resistance placed in series to the RC element was already 
published in literature [Hillebrandt 2001]. 
 
 
Information Content of Cell-Substrate Modelling 
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With EIS, particularly in addition to optical microscopy, changes of the permeability and 
morphology of the cell layer due to biochemical signals can be monitored in real-time. A major 
application is the evaluation of the barrier function of a cell layer, which is normally performed 
by applying a DC voltage over the culture that is supported by a water permeable membrane. 
Using electrically wired impedance chambers as solid supports of the culture is advantageous, 
because cells are then in a more physiologically relevant condition [Wegener 1996]. 
The barrier function is determined by the ion permeability of the cell layer and measured as a 
transepithelial or transendothelial resistance (TER) with the unit Ωcm². TER values of 
epithelial or endothelial tissue are of high scientific interest, because epithelial cells cover all 
inner and outer surfaces of living organisms. In animals, they build up a highly selective 
permeability barrier between blood and tissue, e.g. the blood-brain barrier or the barrier between 
blood and cerebrospinal fluid. Values are in the range of 20 to 10,000 Ωcm² [Powell 1981, 
Hartmann 2007]. 
The TER parameter can easily be measured by EIS [Kottra 1984, Wegener 1996], when the area 
of the sensing electrode is adjusted to the kind of tissue leakage used in the experiment in order 
to keep the absolute resistance measured by the impedance spectrometer in a reasonable range. 
For example, large gold electrodes (0.45 cm²) were used for high resistant MDCK-I cells, and 
small electrodes (0.03 cm²) for cells that do not form tight junctions [Wegener 1996]. 
Impedance analysis on biological materials was reported for several more applications: 
Estimation of microbial biomass [Harris 1985], detection of protein adsorption to supported 
lipid bilayer [Stelze 1989], microbial metabolism [Palmqvist 1994], investigation of changes in 
membranes of biological cells in suspension [Matanguihan 1994], monitoring of enzyme 
reactions [Hintsche 1994], and detection of immunological reactions [DeSilva 1995]. 
In contrast to EIS, single frequency impedance sensing stimulates the sample at a fixed 
frequency rather than over a wide frequency range. This method only focuses on monitoring 
impedance and phase changes with time and is therefore suitable for monitoring dynamic 
processes like cellular motion, adhesion, and detachment processes. 
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2.2.3 Electrophysiological Recording of Action Potentials 
Electrogenic cells generate action potentials (see Chapter 2.1.2) that can be recorded applying 
electro-physiological methods. Upon exposure to harmful chemicals and toxins, cells display 
altered electrical activity and therefore, registration of the electrical activity is an interesting 
sensing principle. Very sensitive and specific sensor systems can be designed using intra- and 
extracellular recording because they take advantage of the cells’ highly specialised biochemical 
pathways. 
Intracellular Recording 
Intracellular recording is performed using an electrolyte-filled micropipette that is inserted into 
the cell. Successful puncture forms a tight sealing between electrode and membrane. The 
membrane potential of the cell equals the potential between electrolyte and culture medium and 
can therefore be registered as the transmembrane potential.  
Monitoring currents through single channels using the Patch-Clamp-Technique involves no 
direct puncture of the cell membrane, moreover a membrane patch is clamped to a 
microelectrode. This is caused by a light suction through the electrode in order to build up a 
tight sealing [Hamill 1981]. In this case, the interior composition is maintained stable what is 
not always the case for other intracellular recordings and also whole-cell Patch-clamp 
recordings as cytosol may leak off. The non-puncturing patch-clamp recording allows direct 
monitoring of ion currents even at the level of single ion channels but has only limited relevance 
for multi-site recording. Additionally, impedance characteristics can be determined by applying 
this method. Fragility of the cell-electrode contact limits the duration of the experiment for all 
intracellular techniques to 2 to 3 hours of observation. Visual control is necessary to approach 
the cell with the electrodes. 
Extracellular Recording 
Disadvantages of the intracellular recording are addressed by applying extracellular recording 
methods. Cells are monitored using microwires placed in their vicinity, or cells were seeded on 
planar electrode arrays that were introduced in the 1970ies by Guenther Gross [Gross 1977]. 
Extracellular recording on microelectrode array (MEA) chips offers non-invasive and long-term 
monitoring of a large number of electrogenic cells. In contrast to the direct measurement of 
potentials using intracellular recording, extracellular recording involves capacitive coupling of 
cells to the electrode (see Figure 2-13 A). Here, local field potentials (LFP) between the basal 
cell membrane and the electrode are measured that evolve from ion currents across the 
membrane (see Chapter 2.1.2). Technically, the LFP is amplified against the counter electrode 
potential and is recorded as a so-called spike (Figure 2-14). Analyses of several parameters 
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derived from spike registration elicit information on the cell culture. Electrical activity therefore 
manifests in spike rate, amplitude, duration, shape, propagation characteristics, and 
synchronicity of the culture for instance. 
A sensor typically comprises 60 electrodes that allow analysis of whole cell networks leading to 
an extended number of parameters because cell activity is also analysed cross-referentially. 
Therefore, applications were mainly developed in neural or cardiac research, as the detection of 
novel pharmaceutical compounds (drug discovery) or the evaluation of known compounds 
(safety pharmacology) [Stett 2003]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-14: Action potentials are recorded extracellularly as so-called spikes. (A) Action potentials of 
cardiomyocytes simulated in HSPICE published by [Borkholder 1998]. (B) The second derivative of the action 
potential represents a close approximation to real extracellular spikes recordings - after [Borkholder 1998]. 
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Coupling of Cells to Planar Microelectrodes 
Successful extracellular recordings depend to a large extent on the quality of the cell-surface 
coupling (see Figure 2-13). A poor sealing of the cell-substrate gap causes leak currents that 
bypass the cell layer and weaken the detection of ion movements. Compared to the amplitude of 
an action potential measured across the membrane, extracellularly recorded LFP are rather 
small. Even for a tight sealing, a cardiac action potential of approximately 60 mV is 
extracellularly monitored as spike with a peak-to-peak amplitude rarely exceeding 2 mV. 
Sealing quality can be expressed by a sealing resistance or a sealing resistor that hinders 
currents to circumvent the cell barrier. In contrast to neurons, cardiomyocytes form a tight 
monolayer on the chip surface and consequently provide a high sealing resistance R, resulting in 
an excellent signal-to-noise ratio. 
The quality of the sealing also affects the shape of the extracellular signal [Borkholder 1998]. 
Impedance analysis was applied to estimate the sealing resistance. 
A simultaneous application of extracellular recording and impedance analysis was published by 
[Rutten 2002]. The electrical activity of neurons can be stimulated in vitro by applying low 
voltage signals across working/counter electrodes. Cells were found to be sensitive only for a 
certain amplitude range of the stimulus signal, which varied with sealing resistance. Below that 
range, cells were not successfully stimulated while cell-destruction occurred above that range 
[Rutten 2002]. Reliability of electrical stimulation may be enhanced by prior determination of 
the sealing resistance using impedance analysis. 
Microelectrode Arrays 
A microelectrode array (MEA) incorporates dozens of microelectrodes integrated on a glass 
substrate. Electrodes are sized 10 to 30 µm in diameter and connected via insulated leads to 
peripheral pads that allow electrode monitoring. 
In Figure 2-15 A, a commercially available MEA chip is shown (Multichannel Systems, 
Reutlingen, Germany). Electrodes are integrated in the centre of the glass substrate. A 
containment ring is placed around the array in order to provide a dish for the cell culture at a 
volume of approximately 1 ml. Generally, electrodes are coated with an impedance reducing 
material (see Figure 2-15 D) to improve the signal-to-noise ratio as titanium nitride, indium tin 
oxide, or platinum black.  
 
 
 
2  Fundamentals  42 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-15: Commercial MEA sensor. (A) Whole device (Multichannel Systems, Reutlingen, Germany). (B) A 
brain slice positioned on the microelectrode array. (C) Scanning electron micrograph of a single microelectrode. (D) 
Titanium nitride coating on electrode [NMI 2003]. (E) Schematic cross-section of a MEA sensor. The cell/electrode 
contact is marked by a circle. Cells were incubated in culture medium (light grey) inside the containment ring. The 
electrode potential was differentially amplified against a counter electrode (GND) via insulated gold leads 
connecting microelectrodes to peripheral pads. 
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The cross-sectional sensor architecture is depicted in Figure 2-15 E. Cellular signals are 
transduced by a differential amplification of the electrode potentials of a cell-covered 
microelectrode and a cell-free counter electrode (GND). Electrically insulating material (Si3N4, 
SiO2) covers the majority of the sensor at a layer thickness of 600 to 1000 nm and is only 
removed at electrode sites. 
The number of electrodes is not limited as the following examples show. A MEA chip was 
manufactured in CMOS technology with integrated multiplexing structures connecting 16 x 16 
electrodes [DeBusschere 1998, 2001]. Another sensor involved the integration of light 
addressable electrodes resulting in a MEA chip with 3600 electrodes. Electrodes were addressed 
by focussing a laser beam on a photo conductor connected to an underlying indium tin oxide 
lead. Using this technique, extracellular recording of cardiomyocytes has been successfully 
performed [Bucher 2001]. 
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2.2.4 Other Methods 
In this chapter some other techniques investigating cell-substrate interaction will be presented in 
short. The addressed techniques offer additional insights and help to understand the phenomena 
inherent to the interface of cells and substrate. 
Minute changes in cell monolayers were quantitatively measured using THz differential time-
domain spectroscopy [Liu 2007]. This technique may become a powerful method when in-situ 
monitoring has been made feasible. So far, cells have to be extracted from the culture medium.  
Real-time extracellular attachment to and detachment from metal surfaces can also be 
investigated by the Quartz Crystal Microbalance technique (QCM) [Gryte 1993, Reiss 2003, Li 
2005]. As cells adhere to the quartz crystal, resonance properties – as frequency and 
bandwidth - change due to mass load and viscous dissipation. For instance, specific integrin-
mediated adhesion of human ovarian cancer cells (OV-MZ-6) to distinct ECM proteins 
immobilised on gold-coated quartz crystal resonators were observed [Li 2005].  
Forces at the cell-substrate interface were determined at high lateral resolution by using 
Traction Force Microscopy. Here, dynamics of cellular movements was visualised by pattern 
recognition of deformations in polyacrylamide substrates. For example, fibroblasts were 
monitored on collagen I [Munevar 2001] or endothelial cells on peptides carrying the RGD 
sequence [Reinhard-King 2003]. Other methods capable of imaging cell adhesion on solid 
substrates are Total Internal Reflection Aqueous Fluorescence and Reflection Interference 
Contrast Microscopy [Reiss 2003]. 
An important technique to determine the width of the cell-substrate gap is the Fluorescence 
Interference Contrast (FLIC) microscopy. This method allows measurement of the distances of 
biological materials to a silicon substrate with an accuracy of a few nanometers [Braun 1997]. It 
takes advantage of the interference of incident and reflected light above a mirror. The standing 
modes of the electromagnetic field above the surface of silicon modulate the excitation and the 
emission of a fluorescent dye, which is inserted into the cell membrane [Sorribas 2001]. 
Experiments revealed that cells compress the laminin cushion during adhesion [Zeck 2003]. 
Thus, the actual gap width is a measure for a balanced force system of repulsion and attraction. 
From these results one might expect that the protein binding force to the substrate is crucial and 
should be at least as strong as the laminin/integrin binding force. 
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2.3 Cell-Based Lab-on-Chip Systems 
This section focuses on whole cell biosensing approaches realised en miniature. Devices that 
apply mechanical and electrical principles to sense biological material are called Biological 
Micro-Electro-Mechanical Systems (BioMEMS). Miniaturisation offers to use BioMEMS as 
point-of-care instruments and for the operation at a patient’s bedside. Another main advantage 
is the simple implementation of an automated assay procedure to perform experiments with 
reproducible (statistically confirmed) results at reasonable cost for material and manpower. 
BioMEMS are designed to work with certain target structures, as molecules or cells. Here, 
selected BioMEMS are presented that investigate suspended or adherent cells. 
2.3.1 Cell Suspensions in Microfluidic Systems 
Cells that are suspended in culture medium are in a specific physiological state, different from 
that of adherent cells. They are less sensitive to shear forces and show a different gene 
expression pattern. Due to their small size (5 - 15 µm in diameter) and general robustness 
suspended cells have been in use with microsystems for twenty years.  
In combination with suspended cells, BioMEMS were used to discriminate different cell types, 
to monitor cellular activity, to quantify DNA, or to insert DNA molecules into cells. In Figure 
2-16 a selection of processing steps that were already implemented in BioMEMS is presented. 
Sample transport was realised by various methods that, for instance, take advantage of 
electrokinetic or electroosmotic properties of cells. During transition, cells were sampled, 
captured, and sorted (e.g. for viability criteria for instance). Depending on the application, cell 
membranes were disrupted or lysed for harvesting cellular DNA or proteins [Bashir 2004, 
Dittrich 2006].  
INLET OUTLET
Sample 
Preparation Selective Capture Viability Control Cell Lysing
Detection of DNA, 
Protein
Sorting, Trapping Antibody based Optical Electrical On-chip PCR
Filtration Electrical Mechanical Nanopores
Electrophoresis Chemical Nanowires
Centrifugation Cantilevers
Sample Transport through BioMEM
Sample Transport
 (electrokinetic, electroosmotic, pressure driven)
 
Sample preparation often includes cell sorting by fluorescence-activated discrimination or 
electrical field-based separation or simply by centrifugation and filtration. Electrophoresis has 
Figure 2-16: Optional processing steps for cells in suspension inside BioMEMS. After [Bashir 2004]. 
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limited applications for manipulation of cells because most biological cells have similar 
electrophoretic mobility [Andersson 2003]. Nevertheless trapping of E.coli from blood samples 
using dielectrophoresis has been reported to result in an enrichment factor above 30 [Bashir 
2004].  
Selective antibody based sampling and viability detection with impedance and fluorescent 
techniques (steps 2 and 3 in Figure 2-16) serve to select specific subsets of viable cells for 
further analysis. 
Cell treatment steps target the release of DNA and proteins by electrokinetic fluid actuation, 
thermal cycling, sonication, electroporation, or pressure application [Andersson 2003]. Analysis 
of DNA and proteins was performed by various techniques that, in case of DNA, include 
amplification by polymerase chain reaction (PCR) or antibody based protein detection on 
cantilevers. Another kind of cell treatment involves the insertion of DNA molecules into living 
cells by electroporation using electric field pulses, puncture by microneedles and microteeth, or 
cell fusion by pulsed electric fields (electrofusion). 
Electrochemical Impedance Spectroscopy Analysis  
Impedance sensing on cell suspensions has been applied to monitor acidification of culture 
medium due to metabolic activity and also to sort cells [Gawad 2001]. A silicon/PDMS-based 
microfluidic device that allows single cell capture, positioning, and drug injection for high 
throughput drug discovery studies is shown in Figure 2-17.  
 
 
 
 
 
 
The device employs low conducting cell culture medium to detect changes in ionic strength 
induced by the metabolic activity of bacteria. Impedance spectroscopy was performed on a 
Figure 2-17: BioMEM investigating bacterial suspensions. 
Scanning electron micrographs of the cell-based biosensor 
published in [Gomez 2001]. (A) The bacteria suspension is 
transported via the channels into measurement cavities (circle; 
530 x 850 x 12 µm³) where impedance sensing on 
interdigitated electrodes is performed. (B) Insertion port for 
macroscopic tubing and measurement chambers. Scale bars 
indicate 80 µm (A) and 300 µm (B). 
A 
B 
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interdigitated electrode in a silicon chamber. Because only few (100…1000) bacteria were 
necessary for detection, the sensor was supposed to be useful in early detection of food spoilage 
[Gomez 2001]. 
Electrical impedance spectroscopy was also used for single cell characterisation of bovine 
chromaffin cells and red blood cells. Sensitivity was sufficient for the discrimination between 
both cell types based on their characteristic impedances [Andersson 2003]. In a different cell 
sorting approach, erythrocytes were distinguished from cells with nuclei removed (ghost cells). 
In this case, the real part of the impedance was monitored at two different frequencies at cell 
transit times of 1 ms [Gawad 2001]. 
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2.3.2 Long-Term Culture Conditions in BioMEMS: Adherent Cells 
The analysis of adherent cultures provides insight to functional behaviour that is more related to 
in vivo situations. But, as stated above, adherent cells are more sensitive to shear stress and 
malign culture conditions than suspended ones. Furthermore, they are plated directly onto the 
sensor device and need to grow there for long periods of time. This long-term cultivation on-
chip raises a number of additional challenging issues. Three issues are important to mention: In 
order to avoid degradation of cells, only biocompatible materials must be used for BioMEM 
device realisation. Silicon dioxide and nitride (SiO2 and Si3N4) as well as PDMS materials are 
widely used for cell-based approaches [DeBusschere 2001, Buitenweg 2002]. Adherent cells are 
very sensitive to shear stress and start to detach from the surface when the shear stress exceeds 
the physiological range of 2 to 14 dyn/cm2 [Park 2003, Zantl: personal communication]. 
Therefore, shear stress of flowing medium inside BioMEMS has to be minimised. And, 
adherent cells owe a limited tolerance to unstable culture conditions. Parameters that might 
cause viability impairment of cells comprise the availability of oxygen and nutrients (inorganic 
salts, amino acids, glucose, serum) and factors as temperature, osmolality, and pH value.  
To estimate the availability of oxygen in closed BioMEMS, the oxygen consumption of 
cardiomyocytes and the maximum solubility of oxygen in culture medium have to be taken into 
account. Those were estimated to approximately 2 to 10 pg / cell / hr [Spier 1982] and 8 ng / µl 
at 37°C [DeBusschere 1998]. 
The pH value is maintained within a narrow range around the cell specific optimum by using 
either a CO2-dependent bicarbonate buffer system or a synthetic HEPES buffer. The importance 
of osmolality arises in sample injection. The osmotic strength of the sample must be adjusted to 
limit osmotic stress across the cell membrane. Although cells are tolerant to osmolalities in the 
range of 260 to 320 mOsm/kg, consistency within ± 10 mOsm/kg should be maintained to avoid 
interference with cellular function. Sample preparation is an important problem that was mainly 
disregarded yet [Freshney 1994, DeBusschere 1998]. 
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2.3.3 Multi-Parameter Sensing of Adherent Cells 
Multi-parameter sensing was performed with the “PhysioControl-Microsystem” that includes 
interdigitated electrode structures and sensors for temperature, oxygen, and pH [Brischwein 
1996, Otto 2003]. A detailed analysis of the cellular microenvironment is feasible as changes in 
pH value, oxygen concentration, or glucose levels can be used as indicators of tumour growth 
[Henning 2004]. 
Another device represents a cell-based biosensor for electrogenic cells with on-site signal 
processing using a CMOS architecture. The system comprises a silicon chip with two closed 
culture chambers attached. Sixty-four sensing electrodes in each chamber and integrated 
circuitry allow for extracellular recording, temperature control, signal buffering, and signal 
multiplexing on-chip. By doing this it was demonstrated that mammalian cells can be cultivated 
inside a handheld, portable device of limited volume [DeBusschere 1998, 2001]. 
An outlook to the future perspective of BioMEMS is provided by the last example (Figure 
2-18). The so-called cell culture analogue is an in vitro device that simulates the exposure of 
mammalian cells to chemicals. The design is based on a model that simulates molecular 
mechanisms of a chemical or its metabolite inside an organism, the so-called physiologically 
based pharmacokinetic (PBPK) model. The microfabricated cell culture analogue device 
contains tissue culture compartments that are interconnected with each other. Different tissue 
types represent some of the basic metabolic properties of the specific organ the cells originate 
from. Blood is mimicked by circulating medium. In pharmaceutical research, existing 
theoretical PBPK models can be analysed using this technique and secondary effects, caused by 
metabolites, may be identified [Park 2003]. 
 
 
 
 
 
 
 
Figure 2-18: Cell culture analogue. (A) Schematic diagram of the different tissue compartments. Circulating 
culture medium is applied through the nozzle (In), transported along an oxygen supply and passes three 
compartments before it leaves the chip at the nozzle (Out). According to a PBPK model, the 1 x 1 inch wide chip 
ensures that certain flow rates feed the chambers. The fat chamber contains no cells, but holds back circulating 
fluids. (B) The actual size of the chip [Park 2003]. 
A B 
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The perspectives of cell-based biosensing shown in this chapter are the basic motivation for this 
work. Two different kinds of biosensing were investigated. On the one hand, the usage of 
microelectrode arrays for impedance-based analysis of cell-substrate interaction was 
investigated. On the other hand, miniaturisation of sensors for monitoring electrical activity 
facilitate compound screening in a highly attractive field of medical and pharmaceutical 
research. In collaboration with an industrial partner this project aimed at the integration of cells 
inside a microfluidic chamber in combination with silicon based fluidic channelling and 
automated fluid dispensing.  
Both were single projects that mounted in a biosensor platform combining both sensor 
principles capable of monitoring cell-substrate interaction and electrical activity in a single 
device.  
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3 Materials and MethodsEquation Chapter (Next) Section 1 
3.1 Biological Material 
3.1.1 Ovarian Cancer Cells 
Tumour cells used for experiments determining cell-substrate interaction have been established 
from a patient afflicted with an ovarian cystadenocarcinoma. The resulting cell line, OV-MZ-6, 
has already been studied with respect to its integrin-mediated adhesion profile to different ECM 
proteins [Hapke 2001, Li 2005]. Cells were maintained in a nutrient mix based on Dulbecco’s 
Modified Eagle Medium (DMEM; Invitrogen, Karlsruhe, Germany) supplemented with 10 % 
foetal bovine serum (FBS; Invitrogen). Additionally, Gentimycin (Invitrogen), HEPES 
(Invitrogen), Arginin (Sigma, Taufkirchen, Germany), and Asparagine (Sigma) were supplied. 
Detailed protocol descriptions for medium preparation and cell culture are given in Chapter 7 
(Appendix). 
Cultivation started with thawing cells from cryoconserved cultures. The additive dimethyl 
sulfoxide (DMSO; Invitrogen) present in the freezing medium was removed by several washing 
steps in the centrifuge (n = 1300 rpm, t = 5 min) at various temperatures and serum 
concentrations. First, cells were rinsed in ice cold medium without serum supplement and 
centrifuged at 4 °C. Washing continued using medium containing 10 % FBS (4 °C), 0 % FBS 
(37 °C), and finally 10 % FBS (37 °C). The centrifuge was operated at room temperature for the 
last two steps. Finally, cells were seeded on tissue flasks at a concentration of 10,000 cells per 
ml and incubated (37 °C, 5 % CO2 in O2).  
Cell cultures were split every 4-6 days by adding 0.025 % ethylene diamine tetraacetic acid 
(EDTA; Biochrom, Berlin, Germany) dissolved in phosphate buffered saline (PBS; Invitrogen). 
After 5 minutes incubation time, cells were transferred into blue caps and centrifuged 
(n = 1300 rpm, t = 3 min). The supernatant was discarded and the cell pellet was re-suspended 
with medium/10 % FBS. Finally, cells were added to tissue flasks at a concentration of 10,000 
cells per ml and cultured as described before.  
For experiments, only cells of a certain developmental stage were considered. Cells must not be 
split more than 12 times after thawing and must be at least two weeks in culture. Only cultures 
with confluency rates between 70 % and 90 % were used for experiments [Reuning, personal 
communication], because adhesion properties change when cells have no space to adhere to and 
thereby enter the lag phase of their development.  
Cells were applied to biosensors precoated with a multiadhesive protein (see Chapter 2.1.1). 
fibronectin (Roche Applied Science, Mannheim, Germany) was coated at a concentration of 10 
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to 50 µg/ml for at least 2 hours at 37 °C. After rinsing, cells were added as a suspension of 
450,000 – 600,000 cells per ml medium/0 % FBS and placed into a table top incubator. Cell-
substrate interaction was only observed under serum-free conditions because serum also 
contains multiadhesive proteins that mediate adhesion and therefore might cause artefacts. 
Cell Viability Assays  
Cell viability was quantitatively analysed either using the MTT assay that was introduced in 
Chapter 2.1.3 or by trypan blue staining. Trypan blue is an intense dye that enters the cell upon 
application. Living cells are able to remove the dye, whereas dead cells do not and therefore 
appear blue coloured. The substance (0.4 %, Invitrogen) was supplied to the culture medium at a 
concentration of 10 % v/v and incubated for 10 minutes. Cell counting revealed a ratio for dead 
versus alive cells.  
The MTT assay is a more precise method [Hendrickx 2003] and allows a more comfortable 
read-out. The yellow coloured MTT solution (5 mg/ml medium) was added to the culture and 
converted to crystals of dark blue colour, MTT-formazan, by mitochondrial dehydrogenases in 
living cells. Turnover was stopped after 0.5 - 3 hours by addition of acidified isopropanol that 
also dissolved the formazan crystals. The cellular viability has been found to correlate to the 
photometric absorption at 570 nm. The spectrometric read-out was performed by an automated 
plate reader (BMG Labtechnologies, Offenburg, Germany) after thoroughly stirring of well 
plates. 
3.1.2 Cardiomyocytes 
Primary cardiomyocytes were prepared from rat hearts of 18 to 19 days old CD rats (E18-19, 
Charles River, Sulzbach, Germany). After hearts of 8 to 11 neonates were removed under sterile 
conditions, they were washed in ice-cold Ca2+- and Mg2+-free Hanks Balanced Salt Solution 
(Invitrogen) and chopped. Because this mixture contained not only heart muscle cells of various 
heart compartments but also connective tissue, several digestion steps followed to discriminate 
the electrogenic tissue type from others. Therefore, the tissue was incubated with 0.025 % 
Trypsin/EDTA (Sigma) for 4.5 min at 37 °C. Ice-cold F10 nutrient mix (Invitrogen) containing 
30 % FBS (Sigma) stopped the enzymatic treatment. Dissociation of tissue was supported by 
performing gentle trituration. Then, cells were allowed to settle and the supernatant, containing 
mostly fibroblasts, was discarded. A second digestive step was performed with the remaining 
tissue (25 min, 37 °C). Again, trituration served to isolate cells from the tissue that were now 
found in the supernatant phase. After tissue residue was allowed to settle down, this supernatant 
was removed and stored on ice. This digestion of tissue residue was repeated until it was 
completely disintegrated. Cell containing fractions were collected and centrifuged (1300 rpm, 
4 °C, 5 min). Then, the pellet was suspended in culture medium (F10/pen-strep/HEPES/10 % 
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FBS) and passed through a cell filter (40 µm pore diameter; BD Biosciences, Heidelberg, 
Germany). Finally, cells were transferred to culture conditions (37 °C, 5 % CO2 in O2). In order 
to separate myocytes from other cardiac cell types like fibroblasts, differential adhesion was 
applied. This takes advantage of different adhesion kinetics of the cell types. Here, fibroblasts 
are mostly settled to the bottom of the culture flask within 120 minutes, whereas myocytes 
remain in suspension. After differential adhesion, the supernatant was harvested. Then, cells 
were seeded to a density of about 6,000 cells/mm2 on sensors pre-coated with 50 µg/ml 
fibronectin (Roche). After 24 hours in culture, FBS content of the nutrient mix was reduced to 
3 %. 
3.1.3 Bioactive Substances 
Integrin Ligands and Control Peptide 
Adhesion of OV-MZ-6 cells can be reversed in the presence of the integrin αvβ3-directed cyclic 
peptide c(-RGDfV-) [Aumailley 1991], because it acts as a competitor for the αvβ3/ECM 
interaction. Whereas the peptide c(-RADfV-) with an exchanged amino acid had no affinity to 
the integrins and therefore served as a control peptide. The lyophilised stock proteins were 
diluted with PBS, and aliquots were stored at -20 °C for up to 3 months. Prior to the experiment, 
peptides were prepared with medium/0 % FBS to a concentration of 250 - 500 µg/ml. 
Photodynamic Therapy with Hypericin 
Hypericin (Sigma) was used as photosensitising agent for Photodynamic Therapy (PDT) of 
OV-MZ-6 cells. Stock solution was prepared with DMSO and kept frozen at –20 °C. Hypericin 
working solutions were prepared with medium/10 % FBS at concentrations between 10 nM and 
1 mM. 
Prior to photoactivation, adherent cells were incubated with hypericin for at least 12 hours. 
Culture vessels were wrapped in aluminium foil to protect the photosensitiser from light. 
Shortly before photoactivation started, hypericin was exchanged against medium/0 % FBS. 
Photoactivation was performed by broad band illumination at a fluence rate of 16 mWcm-2. The 
rate was determined using a power meter (Model 815-SL, Newport Research, USA). 
Detachment of Tumour Cells 
Loosening of the cell-substrate interaction or removal of cells was induced either by addition of 
0.025 % EDTA (Biochrom) in PBS, 0.025 % Trypsin/EDTA (Sigma), or by applying 
mechanical stress to the cells using a Pasteur pipette. 
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Isoproterenol Treatment of Cardiomyocytes 
Isoproterenol bitartrate (Sigma) is a well-known drug for enhancing the heart rate by 
accelerating spike generation in cardiac pacemakers (positive chronotropy). Isoproterenol binds 
to the β-adrenergic receptors and triggers a number of functional activations that in turn enhance 
the entry of calcium through L-type calcium channels (see Figure 2-3). The increased 
intracellular calcium concentration causes a higher spontaneous beat rate [Aravanis 2001].  
Isoproterenol solution was always freshly prepared with F-10 medium/3 % FBS in various 
concentrations before the onset of the experiment. A typical concentration range was 10 pM to 
100 nM. 
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3.2 Sensor Chip Design and Processing 
3.2.1 Microelectrode Array Biosensor for Impedance Spectroscopy 
Overview 
This section focuses on the fabrication of a Microelectrode Array (MEA) chip prototype. Chips 
were used to study cell-substrate interaction of tumour cells with electrochemical impedance 
analysis.  
The sensor device shown in Figure 3-1 comprised the glass chip carrying the microelectrode 
array and a printed circuit board (PCB). Because both parts were assembled by the so-called 
Flip-Chip technology (see page 57), the sensor was referred to as Flip-Chip MEA sensor. The 
devices were characterised by several requirements. For example, the sensors were supposed to 
be re-used and must therefore stand autoclaving conditions. Additionally, multiadhesive 
proteins that are necessary for cellular attachment must be able to adsorb to the sensor surface. 
The MEA were integrated on glass wafers that were fabricated in cooperation with GeSiM 
(Gesellschaft für Silizium-Mikrosysteme, Grosserkmannsdorf, Germany) based on own 
computer-aided design (CAD) drawings. The PCB were ordered from an external supplier 
(Schwind Elektronik, Ulm, Germany).  
 
 
 
 
 
 
 
This kind of sensor assembly had several advantages. Due to the small chip size, 45 sensors 
were manufactured from a single 4˝ wafer at several different designs resulting in reasonable 
production costs per sensor. This approach was appropriate for initially experiencing the 
manufacture process of MEA sensors. 
Figure 3-1: The Flip-Chip MEA biosensor. (A) Microelectrode array (MEA) with differently sized electrodes. 
(B) Biosensor depicted in a top view. The MEA is represented by a small rectangular in the chip centre.  
10 mm200 µm
A B 
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Chip Layout and Processing  
A single chip comprised 60 microelectrodes with diameters from 5 to 40 µm. Each electrode 
was connected to a single peripheral pad. This pad was later bonded to the PCB and covered an 
area of 200 µm x 300 µm. Pads were located at a distance of 500 µm from each other all around 
the chip edges. Fabrication of the chips required CAD drawings of the gold leads structure and, 
separately, the electrode openings of the whole wafer. The drawings were transferred to 
chromium masks (Delta mask, Enschede, Netherlands) or photo emulsion masks. The wafer was 
then processed by a photolithographic procedure called lift-off process that is described below. 
The substrate, a 550 µm thick 4˝ glass wafer (TE-DGS D263 T; Schott Desag, Mainz, 
Germany), was spin-coated with 1400 µm positive standard photoresist and exposed to 
illumination  through a darkfield mask (Figure 2-1 A). Subsequent developing released the 
unexposed areas (B). The whole wafer was then coated by evaporation of 10 nm chromium as 
adhesion layer and 100 nm gold (C). In the following lift-off step (D) the exposed photoresist 
was removed by solvent rinsing leaving the structured glass substrate. The lift-off process is 
schematically shown in Figure 3-2. 
Printed Circuit Board 
The wafer was then insulated with 770 nm SiO2 and/or Si3N4 using Plasma Enhanced Chemical 
Vapour Deposition (PECVD). At last, the insulating layer on the microelectrodes was opened. 
Again, photoresist was spin-coated on the wafer and electrodes were released by exposure 
through a dark-field mask in a second photolithographic step. Reactive ion etching was 
Figure 3-2: Lift-off process. (A) Exposure of photoresist on glass through a dark field mask. (B) Removal of 
unexposed resist. (C) Metal deposition on whole substrate. (D) Release (or lift-off) of gold structure by solvent 
rinsing. 
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performed on the whole wafer, etching away the insulation layer at previously defined electrode 
sites. Finally, the photoresist coating was removed and the wafer diced into 45 single chips, 
sized 11 mm x 11 mm. Before dicing, a protective coating was applied and removed after 
sawing. 
The PCBs measured 50 mm x 50 mm and were structured with gold leads on both sides. A 
square aperture in the centre was 10 mm by 10 mm wide. The MEA chip was glued onto the 
backside with the MEA facing the aperture. Thereby, the peripheral pads on the glass chip were 
bonded to the inner gold lead terminations on the backside of the PCB. These terminations were 
connected to the large pads forming a ring on the PCB front side (see Figure 3-1 B). Hence, 
each pad offered a low ohmic electrical connection to a single microelectrode of the centre array 
and was therefore used by the measurement equipment during experiments. 
Flip-Chip-Technology 
This technology was applied to finally assemble the biosensors. It involves flipping a 
(micro)chip onto a circuit board that was prepared before with precisely applied polymer glue 
spots on electrical contacts. It is used in electronic packaging industries for bonding small series 
production [Lau 1996]. 
First, a stencil printer (SP-002; ESSEMTEC, Switzerland) was equipped with an appropriate 
stencil. This was a 150 µm metal stencil that allowed pasting silver glue (H20E-PFC; Polytec, 
Waldbronn, Germany) spots precisely on the inner gold lead endings on the PCB. Glue was 
spread over the stencil after visual alignment of the PCB and the stencil. The next step involved 
camera-aided alignment of the bumps and counterpads on the glass chip (Fineplacer-145 pico; 
FINETECH, Berlin, Germany) using a X-Y working table. Once the MEA chip and the PCB 
were perfectly aligned, the MEA chip was removed from the alignment position and placed onto 
the PCB. This was the actual flipping process, comprising a 180° turn of the chip that was fixed 
by a vacuum suction to a rotatable arm of the Fineplacer instrument. The chip flipping must be 
very precise to ensure proper bonding.  
Sensor Architecture  
A cross section of a ready-to-use biosensor is shown in Figure 3-3. The MEA chip is shown in 
transverse section with the gold lead connecting microelectrode to peripheral bonding pad, and 
the insulation layer detailed. The silver glue bonding was the central element (circle) that 
connected the MEA chip and the PCB. The bonding site was encapsulated by an underfill resin 
(U-300, Polytec) that was finally coated by biocompatible poly(dimethylsiloxane) (PDMS; 
Sylgard® 184, Dow Corning, Wiesbaden, Germany). Therefore, glass rings served as boundaries 
to prevent the PDMS from covering the MEA. The outer ring (1) also served as a containment 
for culture medium during incubation of cells.  
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Figure 3-3: Biosensor architecture. Figure describes a cross-section through a MEA chip (bottom) bonded to a printed 
circuit board (PCB) by Flip-Chip-Technology. A glass ring (1) served as a containment between cell culture area and 
exterior. 
 
3.2.2 Microelectrode Array Chip for Extracellular Recording 
Overview 
This MEA chip design was different from the one described in section 3.2.1 and fabricated to be 
used for monitoring extracellular activity, exclusively. The chip was planned to be combined 
with an attached microfluidic unit, and therefore it is subsequently referred to as the 
microfluidic MEA chip. Some design rules have been changed, compared to the Flip-Chip MEA 
sensor. The culture chamber, for example, is now obsolete, and instead the challenge of a 
properly sealed fluid system arose. The prior barrier between electrical pads and wet cell culture 
area was now removed due to the attachment of the microfluidic unit. Therefore, the whole 
sensor was immersed in culture medium during cultivation periods. Other changes refer to the 
size of the sensor and the number of electrodes. Both were reduced to ensure handy insertion. 
Additionally, the sensor required an impedance reducing coating on the working electrodes. 
Again, the sensors were fabricated in cooperation with GeSiM (Gesellschaft für 
Silizium-Mikrosysteme). 
Sensor Chip Layout  
In Figure 3-4 A the chip and the microfluidic unit are shown. The culture medium entered the 
system on the left and was transported along a microchannel to the chip, depicted on the right. 
Cells were located on the MEA that is detailed by an inset. The MEA was a 2 x 8 array of 
microelectrodes sized 40 µm x 40 µm and a large electrode (250 µm x 400 µm) that served as a 
counter electrode. The distance from one microelectrode to another was 200 µm (centre-centre). 
Electrodes were connected to large, contact pads (1). The chip was also fabricated using the lift-
off process as described in Chapter 3.2.1. To ensure proper sealing a PDMS gasket was applied 
MEA 
chip 
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onto the insulating layer around the MEA by stencil printing. Photographs of the sensor are 
given in Figure 3-4 B and C. 
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Deposition of Platinum Black  
Platinum black was applied to the gold electrode surfaces as an impedance reducing coating. 
Pt3+ ions were supplied by Kohlrausch’s platinising solution containing 10 mM 
hexachloroplatinic acid IV (Sigma) and 0.4 mM lead citrate II (Sigma) and deposited under 
ultrasonic conditions at DC voltages below 5 Volts (a more detailed description of this 
procedure is given in Chapter 7. Figure 3-5 gives the structure of the surface as an SEM image.  
Figure 3-4: MEA chip for the use in an external microfluidic unit (microfluidic MEA chip). (A) Chip (right) attached 
to the microfluidic unit (left). Dimensions were 19 mm x 13 mm for the chip and 2.5 mm x 0.5 mm for the MEA. 
Inset shows magnified view of the MEA. (1) shows the pad region connected to electronics during experiments 
[GeSiM 2006]. (B) Image of the sensor chip. (C) Enlarged view on the sensor array surrounded by the silicon gasket 
for sealing purposes. 
Figure 3-5: Platinum black coated microelectrode. SEM image of a 40 µm electrode with a scale bar of 2 µm. In the 
inset, a micrograph obtained by conventional light microscopy of the same electrode is shown. 
1
A B 
C 
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3.2.3 Fluidic Chip 
Overview 
The main functions of the fluidic chip were delivery of culture medium and test substances to 
cardiomyocytes during extracellular recordings. The integrated microchannel with an on-chip 
injector has the strong advantage to enable fluid transport at low dead volumes and times. 
Hence, the chip was positioned beneath the microfluidic MEA chip described in Chapter 3.2.2. 
The fluidic chip was also manufactured by GeSiM (Gesellschaft für Silizium-Mikrosysteme). 
General Fluidic Concept 
A schematic cross-section given in Figure 3-6 shows the MEA chip aligned to the microfluidic 
unit. Culture medium entered the microchannel on the left. Test substances were added to the 
medium flow through the injector. The injector was loaded by an external micro-machined 
pipette that was operated in an automated dispenser machine NanoPlotter (see Chapter 3.3.2). 
Typical volumes applied were in the range of 10 µl. The pipette served as an interface between 
substance libraries based on multiwell plates and the microfluidic system. During rinsing the 
injector was left empty, and a ground sieve prevented the intrusion of air into the channel [Fiehn 
1994, Howitz 1999]. After passing the injector, the fluid stream was transported to the cell 
culture located on the up-side-down oriented MEA chip. Finally, the medium with test agents 
left the chip and was discarded. 
 
 
 
 
 
 
 
 
 
Figure 3-6: MEA chip aligned to microfluidic chip. Culture medium was transported along the chip from the left side 
to the right. Test substances were sucked into the micropipette and transferred from a multiwell plate to the injector. 
Here, substances entered the culture medium stream and were moved to the cell culture located on the MEA chip. A 
blocking structure on the bottom of the channel guided the fluid into close vicinity to the cells. Cellular responses 
were displayed on a PC system. 
Culture 
medium 
MEA chip 
Micropipette  
Microfluidic chip 
PC System Injector 
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Chip Architecture 
The chip was composed of a bilayered arrangement of 1 mm thick optical glass underneath a 
three-dimensionally structured silicon wafer of 0.4 mm depth. Glass and silicon were assembled 
by anodic bonding. The fluidic channel of 0.2 mm height was realised by a silicon etching step 
(anisotropic KOH-etching) applied to the back of the silicon chip [Howitz 1999, Richter 1999]. 
On top 100 nm platinum was deposited in order to ensure proper electronic grounding of the 
chip. The total volume of the microchannel was about 1.86 µl. The fluidic chip is shown in  
Figure 3-7: 
 
 
 
 
 
 
Injector 
The injector represents a device for rapid drug application into the microchannel with the 
benefit of preventing air intrusion. Because the injector is located near to the cell chip, drug 
screening with low dead volumes and short sample/rinse cycles was feasible. The orifice 
(2 × 0.5 mm²) of the injector port shown in Figure 3-8 A was equipped with a sieve plate that 
was etched in silicon by anisotropic KOH-etching. Pores were 50 µm in diameter. The transition 
of a drop representing the test substance is given in Figure 3-8 B with culture medium (L1) and 
test substance (L2).  
 
 
 
 
Figure 3-7: Microfluidic chip 
 
Figure 3-8: Injector port in detail. (A) Electron micrograph of the injector. (B) Working principle of the injector. 
[GeSiM 2006] 
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3.2.4 Sensor Chip with Integrated Fluidic Unit 
Overview 
For this third type of sensor a microfluidic silicon chip was irreversibly attached to a MEA. 
Holes and channels were etched into the silicon chip to obtain cell culture chambers and fluidic 
paths for nutrient supply. In contrast to the prior fluidic chip design, culture medium was guided 
across the cell culture at a distance of 300 µm. Because this sensor was used in the platform it is 
referred to as the platform sensor. During experiments, the sensor was inserted into a sample 
holder and covered by a lid that provided a PDMS sealing layer, fluid supply nozzles, and a 
PCB for contacting sensor pads. The sensor is schematically depicted as a cross section in 
Figure 3-9. 
 
 
 
 
 
Two separate fluidic paths were integrated on the silicon chip, one for test substance 
application, the other as a reference path for cells that were not subjected to any test substance 
(control experiment). Each path contained two cell culture chambers in series that were 
equipped with a MEA and/or various impedance electrodes.  
Sensor Chip Layout 
The glass MEA sensor was fabricated by a lift-off process as described before (see Chapter 
3.2.1). Four impedance arrays and two microelectrode arrays permitted impedance analysis and 
extracellular recording. The CAD drawing is given in Figure 3-10. The impedance electrode 
array consisted of two types of working electrodes (30 µm and 300 µm in diameter) opposing 
large counter electrodes, and an interdigitated electrode couple. The microelectrode array was 
composed of 11 electrodes, arranged in a pattern of 200 µm distance to each other (centre-
centre). Two counter electrodes served as a reference node separated from the impedance 
counter electrode. Array electrodes were coated with platinum black as an impedance reducing 
coating. 
 
Figure 3-9: Platform sensor covered by the sealing lid. Cells were cultured on the sensor chip. Culture medium was 
supplied via connectors on top and passed the cell chamber in the direction indicated by the arrow. 
 
Sealing (PDMS) 
Fluidic Chip (Silicon with evaporated Pt on top) 
Sensor chip (Au/Si3N4 on glass) 
flow
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Fluidic Chip Processing  
The fluidic channels (200 µm deep) were etched into a 500 µm thick silicon specimen (sized 
23 x 23 mm) by anisotropic KOH-etching. The chip surface was coated with platinum for 
proper grounding. Bulk etching was performed to carve out culture chambers that had a volume 
of about 10 µl each. 
Assembly of Sensor Chip and Fluidic Chip 
The platform sensor is depicted in Figure 3-11. Both parts were assembled using glue (Endfest® 
300, UHU, Brühl, Germany). Fluid channels led to four culture chambers located in the centre 
of the sensor where the electrode arrays were located. Electrodes were connected to the 
peripheral pad region on the left and on the right of the glass chip. 
Figure 3-10: CAD drawing of electrode structures on the biosensor. The image displays one fluid path with two culture 
chambers aligned. Active electrode structures are shown in light grey, passivated structures in dark grey, and black 
counts for etching borders of the fluidic chip. Hollow black structures were etched through the whole silicon chip, 
whereas solid black structures represent the channel at a depth of 200 µm.  
Figure 3-11: Prototype of the 
assembled biosensor. 
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3.3 Hard- and Software Tools 
3.3.1 Devices for Impedance Analysis  
Impedance analysis can be performed over a range of frequencies (Electrochemical Impedance 
Spectroscopy, EIS) or on a single frequency (single frequency impedance sensing). Whereas 
EIS is used for modelling physical systems, single frequency impedance sensing is an 
appropriate method to determine real-time impedance changes. 
Electrochemical Impedance Spectroscopy 
Broad band impedance analysis was performed using a commercial impedance spectrometer 
(IM6, Zahner, Kronach, Germany) that was operated in the two electrode mode with the 
working electrode and the input from the reference/counter electrode connected to the frequency 
analyser. The cell/culture medium system was excited by a sinusoidal signal of 10 mV in a 
frequency range of typically 1 Hz to 1 MHz. Data analysis, modelling, and fitting algorithms 
were performed in ZVIEW (Scribner, USA). 
Single Frequency Impedance Sensing 
A system capable of single frequency impedance sensing was developed. Stimulation was done 
by a 1 V sinusoidal signal of a fixed frequency chosen between 50 Hz and 120 kHz. As a 
reference source, a sine oscillator module was used (SOM-1, Femto, Berlin, Germany). Changes 
in impedance were detected in real-time by a dual phase lock-in amplifier (LIA-BV-150 H, 
Femto). The impedance was calculated from three voltage outputs ranging from 0 to 10 Volts. 
The impedance magnitude  
 ( )2 2 SignalR X Y U= + =  (3-1) 
is the vector product of the in phase component 
 cossignalX U Zθ ′= =  (3-2) 
and the quadrature component 
 sinSignalY U Zθ ′′= = . (3-3) 
The phase shift between reference source and sample signal is given by 
 arctan X
Y
θ = . (3-4) 
Four parameters were set either manually or digitally to control the lock-in amplifier: 
Sensitivity, coarse phase shift, fine phase shift, and the time constant. 
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Incubating System for Flip-Chip Sensors 
During experiments physiological conditions such as humidity, pH value, carbon dioxide 
concentration and temperature had to be maintained on a stable level. For impedance analysis 
experiments, a table top incubator (Mini-Inkubator S, Zeiss, Jena, Germany) was used. The 
sensor was inserted into a transparent cell culture chamber (Figure 3-13 A) that was connected 
to a CO2 controller (CTI controller 3700, Zeiss) and a temperature controller (Tempcontrol 37-2 
digital, Zeiss) via flexible tubing. Evaporation of the culture medium was reduced by guiding 
the air stream through a humidifier (see Figure 3-13 B).  
Microscopy  
Optical observation of cells cultured on Flip-Chip sensors was performed using a light 
microscope with phase contrast filters (Axiovert 40, Zeiss). Time-lapse imaging was 
accomplished by a CCD camera (XC-ST50CE, Sony, Japan) and a PCI frame grapper card 
(PXC-200, Stemmer Imaging, Puchheim, Germany). 
Multiplexing Electrodes 
Impedance sensing focused on the observation of just a single electrode. To overcome this 
limitation, a PC controlled 16 channel multiplexer was realised for usage in the biosensor 
platform. The multiplexer PCB is shown in Figure 3-12.  
Figure 3-12: Impedance channel multiplexer. The impedance electrode was connected via a relay controlled line. The 
particular relay was activated via a 16 channel multiplexer unit. A 4 bit scheme transmitted via 4 digital lines allowed to 
control the relay. 
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Using this device, any single electrode of the impedance array (see Figure 3-10) can be 
observed and measured sequentially. For each electrode a set of specific lock-in parameters 
(sensitivity, coarse phase shift, fine phase shift, time constant) had to be transmitted, which was 
performed by the application software described in Chapter 3.3.3.  
 
 
 
 
 
 
 
 
Figure 3-13: Sensor incubation system. Incubation ambience is provided by an humidifier, a CO2-controller and a 
thermostat (not shown) located upstream of the tubing inlet (1). The gas stream circulates around the MEA sensor 
that is located on the bottom. The sensor is accessible be removing the lid.  
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3.3.2 Devices for Extracellular Recording  
Sample Holder for Sensor and Fluidic Chip  
The first microfluidic biosensing system was exclusively used for extracellular recording. The 
(microfluidic) MEA sensor and the fluidic chip, described in detail in Chapters 3.2.2 and 3.2.3, 
were set into an aluminium sample holder during experiments. The holder is given as a CAD 
drawing in Figure 3-14. 
The MEA sensor was attached to the fluidic chip by means of a mechanical clamp mechanism. 
The PDMS gasket printed on the MEA chip ensured leak-free operation. Cells were 
continuously fed with cell culture medium using a peristaltic pump (IPC-N, Ismatec) and 190 
µm wide biocompatible tubing (Pharmed, Ismatec, Wertheim, Germany). The pad region on the 
MEA chip was contacted by springs that led to a socket integrated on a printed circuit board. 
The holder was kept at a physiological temperature of 37° C controlled by a heating circulator 
(ME-26, Julabo, Seelbach, Germany). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-14: Sample holder of the first microfluidic concept given as a CAD drawing. The MEA cell chip was 
clamped onto the microfluidic unit with cells orientated downwards. Culture medium was supplied along the 
(white dotted) fluid path. Electrical signals were acquired from MEA chip pads via spring contacts, printed 
circuit board, and surface mounted socket [GeSiM 2006].  
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Computer-Controlled Fluid Dispenser 
Test substances were applied to the injector opening of the fluidic chip manually or by using a 
fluid dispenser (Nanoplotter 1.2; GeSiM) shown in Figure 3-15 A. During experiments the 
sample holder was caged by a housing connected to electrical ground in order to shield the 
electronic circuitry from noise pickup. Sample holder and housing were mounted on the 
working table (Figure 3-15 B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-15: Fluidic dispenser with the sensor setup mounted on top. (A) Dispenser and (B) Sample holder.
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Precise positioning of a micropipette (SPIP A-010; GeSiM) within the range of the working 
table was achieved by computer-controlled linear drives. During operation, the pipette tip was 
first moved to a defined well on the multi-well plate to aspirate a 5-10 µl load of a test 
substance. Then, the pipette was moved to the sample holder and the test substance was 
dispensed into the injector. Finally, the pipette was rinsed in a washing station to remove 
residual test substance from the tip.  
Within the centre of Figure 3-16 (circle), the pipette tip is positioned above the injector, ready to 
dispense a test substance into the fluidic chip. Application software (np8; GeSiM) provided 
implemented functions for precise coordinate addressing of the pipette head and various other 
operations. 
 
 
 
 
 
 
 
 
 
 
Figure 3-16: Fluid injection using the Nanoplotter. The micropipette is about to apply a substance onto the injector of 
the microfluidic chip (circle). Large tubing in the foreground guide thermostated water through the sample holder 
and culture medium is transported in the small tubing on the right. The sample holder was thermo-insulated from the 
ground plate of the shielding cage by a sheet of Teflon. 
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Data Acquisition and Processing 
The output of the MEA chip (see Chapter 3.2.2) was fed into a 64 channel differential input 
filter-amplifier (F-64; Multi Channel Systems MCS GmbH, Reutlingen, Germany). The device 
was characterised by a low cut-off frequency of 200 Hz, a high cut-off frequency of 5000 Hz, 
and a voltage gain factor of 1200. The amplifier output was connected to a PCI data acquisition 
card (MCCard; MCS) on a standard PC system. Data analysis was performed with the 
application software MCRack (MCS). 
Second Generation Recording System 
The commercially available recording system described before was not used in the second 
approach, the biosensor platform. Amplification of the local field potentials had to be performed 
in close vicinity of the sensor to reduce pickup of noise. Therefore, a multichannel amplifier 
was developed and manufactured. In Figure 3-17 the amplifier PCB is shown. It was mounted 
onto the multiplexing board inside the aluminium box. The PCB was realised at similar 
specifications as the commercially available amplifier, except for the number of channels that 
was reduced to 20 and for the gain factor that was slightly increased compared to the amplifier 
previously used. Due to a central hole (diameter 13 mm) in the circuit boards, optical 
observation through the aluminium box was made feasible.  
 
 
3.3.3 Concept and Components of the Biosensor Platform 
The biosensor platform allowed to measure cell impedances and record cellular activity at the 
same time. Additionally, optical observation offered visual control of cells and fluid chambers. 
After the sensor and the transducing systems have already been described in detail (Chapters 3.2 
Figure 3-17: Filter amplifier board. 20 
channels were differential input filter-
amplifier differentially amplified against a 
reference potential (differential input filter-
amplifier). The board was sized 165 mm by 
165 mm and mounted inside the aluminium 
housing with the electrode multiplexer 
board beneath. In the centre, the circuit 
board includes a central aperture for optical 
observation using a light microscope. 
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and 3.3), the rest of this chapter focuses on the sensor holder, the optical observation equipment, 
and the application software. But first, an overview of the system concept is provided. 
System Concept 
The core concept of the screening system is shown in Figure 3-18. Signal acquisition is 
displayed following the processing pathway from the biosensor source via sample holder and 
set-up electronics to final data display and storage. Multichannel signals were drawn in bold 
lines.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-18: Schematic concept of the biosensor platform. Signals originated from the biosensor (top right) and were first 
processed in the multichannel amplifier and the multiplexer unit located beneath the sensor holder. Then, signals were 
transferred to the electronic setup and displayed on screen.  
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The electrodes of the biosensor were connected to the multiplexer board and multichannel 
amplifier. As described above, both were located in an aluminum housing close to the sensor 
holder. The output of these devices, the single multiplexed impedance channel and the 20 
amplified microelectrode channels, were connected to the external set-up electronics. 
A rack was assembled what contained a lock-in amplifier, power supplies, and a converter 
board, as the drawing of the front panel shows (Figure 3-19 A). Multichannel signals first enter 
the converter board, where channels were rearranged according to the specifications of the 
commercial amplifier (F-64; MCS, Reutlingen) which was used for compatibility reasons. The 
multiplexer output was connected to the lock-in amplifier that encoded the impedance as in-
phase component X, quadrature component Y, and impedance magnitude R, as described in 
equations (3-1) to (3-3). The input of the lock-in amplifier was also guided to a connector for an 
external broad band impedance analyser. Digital registry was used for controlling the lock-in 
module, the multiplexer, and also an external valve. 
 
 
 
 
 
 
 
Figure 3-19: Set-up electronics. (A) Drawing of set-up electronics front panel. Rack includes power supplies, external 
valve control, lock-in amplifier, and converter boards. (B) Photograph of the device. 
 
The rearranged multichannel lines and the three impedance channels X, Y, and R were then 
transferred to the PC system. Therefore, two 16-channel data acquisition cards (DAQcard 
6062E, National Instruments, Munich, Germany) were connected to the PCMCIA interface of a 
notebook (Latitude 610, Dell, USA). The cards worked as an A/D converter, accomplished data 
acquisition at 500 kilosamples per second, and offered 16 digital control channels. Cards were 
controlled by LabVIEW (National Instruments) based software. 
Sensor Holder of the Biosensor Platform 
Cells were grown and cultured on the sensor chip outside the measurement system in culture 
medium located in petri dishes (Figure 3-20 A). When used for experiments, the sensor was set 
into the temperature controlled sample holder (see lower square in Figure 3-20 B). It was 
B A 
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covered using a lid (upper square) that carried a printed circuit board to connect sensor pads to 
peripheral electronics and that sealed the measurement cell. The closed cell chamber is shown in 
Figure 3-20  C+D. 
A plain PDMS layer on the lower surface of the polymethyl methacrylate (PMMA) lid sealed 
the top side of the platform sensor. Furthermore, fluid supply nozzles fit onto the outer 
terminations of the integrated microchannels. A peristaltic pump (IPC-N; Ismatec, Wertheim, 
Germany) transported cell culture medium via microchannels to the cell chambers at flow rates 
of 10 to 100 µl/min. Sterility of the fluidic system was provided by Teflon coated silicone septa 
on supply vessels and autoclavable tubing (Pharmed; Ismatec).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Optical Observation System 
Optical observation of the cell culture within the platform sensor was performed by a light 
microscopial setup composed of a zoom objective (Opto Sonderbedarf, Gräfelfing, Germany), a 
CCD camera (XC-ST50CE; Sony), and a frame grapper card (PXC-200; Stemmer imaging, 
Figure 3-20: Sample holder of the sensor platform. (A) Sensor chip immersed in culture medium. (B) The sensor 
(bottom square) was placed on the sample holder. The lid is hanging above (top square). (C) Side view on sample 
holder with mounted cell chamber and the microscope objective. (D) Top view through the PMMA lid onto the 
sensor. 
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Puchheim, Germany). Illumination was provided by a broad band light source (HBO 50 35W; 
Zeiss, Jena, Germany) that coupled light into the system by a beam-reflector. A polarisation unit 
was used to improve the image contrast. 
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Application Software 
The LabVIEW application software displayed, processed, and stored data acquired from 
extracellular recording and impedance analysis. Moreover, control of the lock-in amplifier was 
performed using LabVIEW functions via digital channels of the data acquisition cards. The 
software was based on the work of a diploma student who implemented a routine to efficiently 
process high volume data as are obtained from extracellular recordings [Steininger 2005].  
The application software contained three major panels; The control bar (see dashed rectangle in 
Figure 3-21) indicated information on the status and the signal output of the lock-in amplifier. 
Additionally, it controlled display parameters, spike detection parameters, impedance 
recordings, and extracellular recordings. Two specific screens were programmed for analysis of 
extracellular recording data or impedance sensing data, respectively. Screenshot images of the 
operating surface are given in Figure 3-21 A and B. Operations that were integrated in the 
software are listed below. 
• Protocol: Observations or present parameter settings were written as comments 
stored with precise time information. 
• Data storage: Spiking activity or impedance changes were recorded as data files in 
ASCII format (termination was performed manually or automatically by a count-
down-mode). 
• Spike detection: Threshold values were set manually for each electrode channel to 
allow determination of the spike rate (spikes per time). Spike counting was ceased 
for a defined time period after a spike event was recorded to prevent artefacts as 
multiple counting of the same spike. 
• Replay tool: Analysis of extracellular recordings was performed by reviewing data 
as single spike trains (see Figure 3-22). 
• MUX controlling: The lock-in amplifier required electrode specified settings. 
Optimal settings for time constant, sensitivity, and phase correction values were 
determined during the beginning of an experiment and stored in a matrix for all 
electrodes. In the multiplexer mode, values for the sensed electrode were 
transmitted to the digital input of the lock-in amplifier (Figure 3-21 B).  
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Figure 3-21: Screenshot images of the application software. (A) Screen used for the analysis of extracellular 
recordings. (B) Screen for impedance sensing analysis. The control bar is highlighted by a dashed rectangle. 
A 
B 
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Figure 3-22: Spike train of a period of 20 seconds displayed on the replay tool. 
 
The screen for monitoring extracellular recordings is presented in Figure 3-21 A. The amplified 
local field potentials were displayed in an array of 20 electrodes referring to the geometry on the 
MEA chip array. In Figure 3-21 B the screen is shown that was used for monitoring impedance 
sensing. Here, the control matrix of electrode number and lock-in pre-settings were adjusted 
prior to each experiment. Three graphs represented impedance parameter magnitude R, in-phase 
component X, and the quadrature component Y.  
The review tool for extracellular recordings is presented in Figure 3-22. Stored data was loaded 
into the program and displayed as a single spike train for each electrode. Zoom functions on 
both axis and a bandstop filter were useful to reveal information even from data with a low 
signal-noise ratio and at different time scales. 
4  Results and Discussion  79 
  
4 Results and DiscussionEquation Chapter (Next) Section 1 
4.1  Investigation of Cell-Substrate Interaction 
Cell attachment and detachment processes of human ovarian tumour cells (OV-MZ-6) on Petri 
dishes or microelectrode array (MEA) chips were monitored by EIS, single frequency 
impedance sensing, and optical phase contrast microscopy.  
Two different approaches were followed that are both related to anti-cancer strategies: 
Monitoring of 
 the competitive binding of synthetic ligands to αvβ3-integrins on the cell membrane and  
 the effect of photodynamic therapy (PDT) using photoactivated hypericin. 
4.1.1 Experimental Set-up 
The Flip-Chip MEA sensor (see Chapter 3.2.1) was inserted into the incubation system (Chapter 
3.3.1) and placed on a microscope stage as depicted in Figure 4-1. The peripheral sensor pads 
on the sensor circuit board were connected to an external impedance analyser. 
 
 
 
 
 
 
 
 
 
Figure 4-1: Setup used for analysis of cells on Flip-Chip MEA biosensors. Impedance analysis and optical 
microscopy were synchronously performed. Experiment was performed at 37°C. 
Sensor 
Objective  
Incubator 
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4.1.2 Dynamic Cell-Substrate Interaction 
Optical Characterisation of Tumour Cell Adhesion 
This section focuses on visual observation of cellular behaviour during attachment and 
detachment. Fibronectin (Roche Applied Science, Mannheim, Germany) was applied to a 
proportion of a Petri dish at a concentration of 50 µg/ml diluted in PBS. Then, OV-MZ-6 cells 
were added at a concentration of 400,000 cells per ml and incubated for 24 hours. 
Cells exclusively settled down to the area precoated with fibronectin, and no attachment was 
observed on the area devoid of coating (Figure 4-2). Cells in suspension appeared as spherical 
objects surrounded by a halo (see cells on top of Figure 4-2), whereas adherent cells revealed a 
flattened, darkly shadowed, and often polygonal shape. As a result, coating of multiadhesive 
protein was found to be crucial for successful cell adhesion in vitro. 
 
In Figure 4-3, a group of cells was observed during a time period of about 6 hours. Time lapse 
imaging allowed demonstrating different stages of cellular attachment, motility of adherent 
cells, and even proliferation. Cell attachment was observed focusing on a proliferating cell and 
its offspring (red arrows). In this representative case, the proliferating cell was adherent (no 
image shown) before observation started. Shortly before mitosis, it changed to a spherical body 
(image 1) that was also observed when cells in suspension were added and started to interact 
with the substrate. Shortly after mitosis, the offspring cells formed focal adhesions (image 2) in 
analogy to (former) suspended cells shortly after attachment. After about one hour, this initial 
cell attachment was finished (image 5) and cells began to spread out on the surface. These two 
phases were related to stages of cell attachment, cell adhesion and cell spreading. Cell motility 
is clearly reflected by images 11 and 12 that were acquired at a time interval of 2 hours and 22 
minutes. 
Figure 4-2: Fibronectin coating 
mediates cell adhesion. Phase contrast 
microscopy image of OV-MZ-6 cells 
on a polystyrene dish, partly precoated 
by fibronectin. The image was taken 
four hours after cells were applied to 
the sensor. Experiment was performed 
at 37°C.  
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Figure 4-3: Cell attachment during cell proliferation. Micrographs show a part of a polystyrene dish laced inside the 
incubator and incubated with OV-MZ-6 cells. Image acquisition is indicated in the format of [hh:mm]. Especially the 
upper offspring cell (see arrows) started to increase its size strongly between images 4 and 6. This process is called 
cell spreading. Motile activity was particularly documented between images 11 and 12 (time interval: 2:22). 
Experiment was performed at 37°C. 
 
Impedance Spectroscopy of Adherent Tumour Cells 
Attachment and detachment of tumour cells at 37°C.were monitored by Electrochemical 
Impedance Spectroscopy (EIS) on Flip-Chip MEA sensors. Therefore, electrodes of various 
sizes were connected to a frequency response analyser in a two-electrode configuration and cells 
were seeded to the sensor surface. Cultivation of cells took place as described in Chapter 3.1.1.  
The impedance spectrum of a 30 x 30 µm² gold electrode is shown during the course of a single 
experiment in Figure 4-4. The Bode diagram covers a frequency range of 100 Hz to 1 MHz. The 
initial bare electrode impedance is represented by a solid line. In this situation, only a precoating 
of adhesive protein was adsorbed to the electrode surface. The second impedance scan (dashed 
line) was recorded after the electrode was covered by a confluent cell layer as also shown in the 
image inset. The dotted impedance spectrum was recorded at last after the cells were removed 
from the sensor surface by adding 0.025% EDTA binding bivalent ions crucial for cell 
adhesion. 
1:07 65 7 81:27 1:47 2:08
2:49 109 11 123:09 3:29 5:51
start 21 3 40:06 0:27 0:47
20 µm
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Within a frequency range of 10 to 600 kHz, cell attachment caused a substantial increase of 
impedance magnitude (up to +172 % at 100 kHz; Figure 4-4 A). The system response almost 
returned to initial values after cell detachment was induced.  
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Figure 4-4: Cell-substrate interaction monitored by EIS. Data is presented as a Bode diagram with (A) magnitude 
plot and (B) phase plot. First, the electrode impedance of a bare 30 x 30 µm² large microelectrode was monitored 
(solid line; ‘Bare’). Then, OV-MZ-6 cells were added that built a confluent layer after approx. 3 hours (inset 
image; dashed line; ‘Monolayer’). Finally, cells were removed from the sensor surface by EDTA administration 
(dotted line; ‘Bare (after detachment)’). ‘X’ marks in (B) refer to impedance phase maximum values for cell 
covered and bare sensors. 
Monolayer 
Bare (after detachment) 
Bare 
A 
B 
X X 
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Impedance phase characteristics were also influenced by the formation of a cell layer on the 
electrode (Figure 4-4 B). The maximum value of the impedance phase (X in Figure 4-4) 
correlated well with the state of cell attachment. First, 200 - 300 kHz were registered for the 
initial cell-free situation. Then, after cellular attachment to the electrode, the maximum value 
shifted to 20 kHz. Measuring the impedance phase after removal of cells confirmed that the 
frequency shift of the maximum value is almost reversible.  
The effect of attachment became even clearer when the impedance magnitudes of both cases 
were compared (Figure 4-5). Obviously, the system was not equally sensitive over the entire 
frequency range – a peak was found to be located at 70 kHz for the 30 x 30 µm² electrode used. 
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Figure 4-5: Optimal sensitivity of monitoring cell-substrate interaction. Cellular attachment was monitored by 
Impedance Spectroscopy and normalised to bare sensor conditions.  
Sensitivity 
maximum at 
~ 70 kHz 
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Analysis of Cell-Substrate Interaction 
Data of several experiments investigating adhesion and detachment of OV-MZ-6 cells were 
analysed by equivalent circuit modelling in order to determine parameters that reflect cell-
surface interaction. The model used was already presented in Figure 2-13 D and is now given 
again in Figure 4-6. It comprises a constant phase element (CPE) counting for the surface of the 
microelectrode and a RC element representing the electrode coating. An additional non-linear 
component in series to the resistance counting for diffusion related phenomena might increase 
the accuracy of modelling but would also result in a higher variance of model elements 
[Hillebrandt 2001]. 
 
 
 
 
The accuracy of the modelling process is illustrated in Figure 4-7 that comprises measured data 
(circles) and the resulting fitting curve (solid line).  
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Figure 4-6: Equivalent circuit used for modelling EIS data.
Figure 4-7: Modelling accuracy. (A) Magnitude plot and (B) phase plot of EIS data that was acquired from a bare 
electrode (30 µm diameter; circles) and fitting curve (solid line). 
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Parameter extraction revealed a correlation of the model parameter resistance R to cell-substrate 
interaction (Table 4-1), whereas CPE parameters and capacitance C did not correlate (Table 
4-2). Resistance R increased strongly for monolayer formation (Adhesion) whereas culture 
medium exchange (Control) only caused a weak increase that can be referred to further protein 
adsorption from FCS supplement. That might have been tested by a control experiment by 
flushing without FCS. Detachment by either chemical, enzymatic, or mechanical treatment 
(0.025 % EDTA, 0.25 % Trypsin/EDTA, Pipette flush) led to a decrease of resistance R. The 
latter, Pipette flush, involved mechanical removal of cells by rinsing using a Pasteur pipette. 
Table 4-1: Change of resistance in adhesion and detachment experiments. Data was normalised to bare electrode 
results (bare electrode = 0) in the cases of Control and Adhesion and the fitting result of an electrode covered by a 
confluent monolayer in the cases of EDTA, Trypsin and Pipette flush. Additionally, the standard deviation (SD) and 
number of experiments performed are indicated. 
Experiment Type Change of Resistance SD Experiments 
Control 0.504 0.181 5 
Adhesion 3.182 2.445 12 
EDTA -0.703 0.249 3 
Trypsin -0.670 0.206 6 
Pipette flush -0.625 0.312 4 
 
Table 4-2: Change of capacitance in experiments. Number of experiments as indicated above. 
Experiment Type Change of Capacitance SD 
Control -0.064 0.158 
Adhesion -0.034 0.506 
EDTA 0.370 0.436 
Trypsin 0.262 0.436 
Pipette flush 0.068 0.335 
 
Table 4-3: Change of CPE-T parameter in experiments. Number of experiments as indicated above. 
Experiment Type Change of CPE-T SD 
Control 0.256 0.169 
Adhesion -0.143 0.547 
EDTA 0.393 0.250 
Trypsin 0.215 0.251 
Pipette flush -0.065 0.180 
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Dynamic Cell Adhesion 
The ongoing process of OV-MZ-6 cell attachment was monitored by EIS on the same type of 
electrode as previously shown (30 x 30 µm²). Cell attachment to the sensor is displayed by 
superimposed spectra that were acquired at interval of 20 minutes in a single Bode diagram in 
Figure 4-8. 
During the first hour of measurement no response was observed. Then, during the following 80 
minutes impedance magnitude rose and the phase maximum shifted to lower frequencies as 
described before. Both kinds of impedance representations show that cellular attachment to the 
sensor is not recorded equally over the whole frequency range. At 600 kHz, adhesion was 
measured already within the first hour. In contrary, during this time period no response was 
monitored at 10 kHz. This finding is illustrated in Figure 4-9 by normalisation of impedance 
magnitude values to initial bare electrode values. 
The delay of the response for certain frequencies is an important finding for setting up the single 
frequency impedance analysis system. The frequency used for system stimulation has to be 
chosen carefully under consideration of the type of experiment. A cell adhesion experiment 
involving a bare sensor would require a higher stimulation frequency than an assay with already 
cultured cells on the sensor observing the detachment (e.g. invasion of tumour cells into 
confluent cell culture). A comparison of three different frequencies is given in Figure 4-10. 
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Figure 4-8: Dynamic cell adhesion monitored by EIS. (A) Impedance magnitude plot. (B) Impedance phase plot. 
Monolayer formation is shown on a single microelectrode at a time interval of 20 minutes. Open circles reflect the 
condition prior to cell addition. 
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Figure 4-10: Dynamic cell adhesion evaluated for three different stimulation frequencies. 
Figure 4-9: Change of impedance magnitude during dynamic cell adhesion. Cells were seeded on the sensor at 
time zero. Attachment was first observed at high frequencies (500 kHz). Completion of the monolayer was most 
sensitively monitored at 70 kHz. 
Electrode size: 30 µm  
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Impedance Sensing at Single Frequencies 
Cellular attachment was monitored using the impedance sensing device described in Chapter 
3.3.1. Because the voltage output of the system was non-linear, the system was calibrated as 
described in Appendix E. The sensing frequency was varied in order to confirm previous 
statements on frequency dependencies. Additionally, the influence of the electrode size was 
investigated by using differently sized working electrodes (Figure 4-11).  
Previous findings for multi-frequency measurements were confirmed on electrodes of 30 µm 
diameter (Figure 4-11 A). The 95 kHz impedance signal showed a higher sensitivity than the 
10 kHz signal. The cellular response in both experiments was monitored almost instantly which 
is in contrary to the case presented in Figure 4-8. Here, the signal did not change for about one 
hour. Presumably, the coverage of the electrode differs from experiment to experiment revealing 
different adhesion kinetics. Following this idea, the experiment presented in Figure 4-8 might 
document the situation of a bare electrode that has been covered by cells late during the course 
of the experiment.  
Interestingly, a strong influence of the size of the working electrode was found, too. On working 
electrodes with a diameter of 300 µm (Figure 4-11 B), the lower frequency was found to elicit a 
more sensitive signal.  
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Figure 4-11: Single frequency impedance analysis for cell attachment. Cell attachment monitored by single 
frequency impedance analysis at 95 and 10.4 kHz. (A) 30 µm electrode size. Signal interruptions result from 
the transfer of the sensor to an external microscope. (B) 300 µm electrode size. Experiment was performed at 
37°C. 
A Electrode size: 30 µm 
Electrode size: 300 µm B 
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4.1.3 Integrin Ligand Induced Cell Detachment 
Investigation of cell-substrate interaction so far involved either total attachment or total 
detachment of cells in rather exemplary situations. These experiments only represent the spread 
of possible responses. This chapter now, monitors the influence of an integrin ligand that 
competitively binds to the tumour cells. Therefore, OV-MZ-6 cells were cultured on Petri dishes 
and Flip-Chip MEA biosensors until confluence. Optical microscopy, EIS and single frequency 
impedance sensing were performed on working electrodes sized 30 µm. 
After recording of the initial electrode impedance, the integrin ligand c(-RGDfV-) or the control 
peptide c(-RADfV-) were added at a concentration of 500 µg/ml, and the response was 
monitored for a period of about 2 hours. Tumour cells started to lose contact to the substrate and 
detached after addition of c(-RGDfV-) (see Figure 4-12).  
 
 
 
 
 
In Figure 4-13, impedance spectra of cells that experienced integrin ligand-induced detachment 
are compared to spectra of bare and confluent covered biosensors. After addition of 
c(-RGDfV-), impedance magnitude decreased during two hours of incubation.  
The mechanism behind is supposed to be a higher affinity of the synthetic integrin ligand to the 
RGD binding site compared to one of the multiadhesive protein. An interesting control 
experiment would have been to monitor the response of un-attached cells to immobilised 
c(-RGDfV-) on the sensor surface. 
Results of the model parameter resistance R for the described integrin ligand assays and other 
detachment processes are given in Table 4-4. No change was observed after c(-RADfV-) 
application, while c(-RGDfV-) resulted in an impedance magnitude decrease as seen for 
previous detachment assays. The response is weaker because this kind of cell detachment still 
leaves residual cells behind.  
In summary, real-time monitoring was performed using impedance analysing techniques in a 
more efficient way as e.g. the manual cell-counting assay. Automatic screening of large 
substance libraries for their potency to induce tumour cell detachment is in principle possible 
with this approach, offering a true real-time assay. 
Figure 4-12: Integrin induced 
detachment monitored by 
microscopy. Images represent the 
same group of cells before (A) and 
after (B) administration of 
c(-RGDfV-) for 2 hours and 14 
minutes. Experiment was 
performed at 37°C. 
A B 
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Figure 4-13: Integrin ligand induced detachment monitored by EIS. (A) Impedance magnitude for the bare 
electrode, the cell covered electrode, the electrode after 2 hours of incubation with c(-RGDfV-) peptides, and 
cell-free sensor induced by EDTA application. Legend is applicable for both diagrams. (B) Impedance phase.  
A 
B 
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Table 4-4: Fitting parameter R for integrin-ligand induced cell detachment. The impact of various treatments on the 
normalised resistance R is displayed: Integrin ligand c(-RGDfV-), the control peptide c(-RADfV-), chemical, and 
mechanical detachment methods. Values were extracted from the model circuit presented in Figure 4-6. 
 
 
 
 
 
4.1.4 Photodynamic Therapy 
This chapter also investigates whether impedance analysis can also be used to monitor the effect 
of Photodynamic Treatment or Therapy (PDT). This treatment involves local injection of a 
photosensitiser into tumour tissue and its subsequent irradiation. During PDT, a high proportion 
of cells that have taken up the photosensitiser are destroyed which can possibly be measured as 
an impedance decrease of the electrode/cell system. 
Standard Procedure and Parameter Definition by Assaying Cell Viability  
The procedure of PDT is drawn schematically in Figure 4-14. Confluent human ovarian tumour 
cells (OV-MZ-6) were cultured on multi-well plates and incubated with hypericin at various 
concentrations for at least 12 hours. Then, broad-band irradiation was performed at varying 
exposure times. Cell viability was evaluated by examining trypan blue or thiazolyl blue 
tetrazolium bromide (MTT) assays, described in Chapter 3.1.3. Incubation time was 5 minutes 
in the case of the trypan blue assay and 60 minutes in the case of the MTT assay. 
 
 
 
 
 
 
 
 
 
 
Experiment Type Change of Resistance SD Experiments 
c(-RGDfV-) -0.374 0.498 8 
c-(RADfV-) 0.010 --- 1 
EDTA -0.703 0.249 3 
Trypsin -0.670 0.206 6 
Pipette flush -0.625 0.312 4 
Figure 4-14: Photodynamic Therapy. 
(A) Cells were seeded on the sensor chip - black areas 
represent sensing electrodes. 
(B) The photosensitiser was incubated for at least 12 hours 
and subsequently photoactivated … 
(C) … resulting in a decreased cell viability and gap 
formation on the sensor surface. 
 
  Photoactivation
A
B 
C
<1 µM Hypericin
> 12 hrs
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Trypan blue staining involved evaluation of the ratio of blue coloured and transparent cells by 
manual cell counting. In contrast, the MTT assay allowed automated plate reading and therefore 
cell viability was mostly assayed by this technique. The spectrometric absorption of the 
irradiated well content (composed of culture medium, MTT, formazan product, stopping 
solution, and cells) was measured at a wavelength of 570 nm and normalised to non-irradiated 
control wells. No visual effect was observed for irradiating cells without prior hypericin 
treatment. 
In Figure 4-15 the effect of PDT is displayed for varied photoactivation duration and different 
hypericin concentrations. Cell viability was reduced up to 50 % for increasing hypericin 
concentrations and irradiation periods. Cells were barely impaired after treatment with 200 nM 
Hypericin. Due to the multiparametric character of this technique, it is difficult to confirm data 
by literature. Hendrickx et al. [Hendrickx 2003] applied similar Hypericin concentrations at a 
fluence rate of 4.5 mW/cm² using fluorescent lamps and received an IC-50 value of 80 nM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-15: Cell viability after multiparametric PDT performed at 37°C.. Cells were treated with hypericin at 
denoted concentrations, subsequently irradiated at a fluence rate of 16 mWcm-² for the given photoactivation 
period, and finally evaluated using the MTT assay. Data were normalised to non-irradiated samples. 
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Visual Observation  
The effect of PDT on a culture of OVMZ-6 cells at 37°C was investigated visually by light 
microscopy. Hypericin concentration and exposure time of PDT exceeded the ones applied for 
the previously presented MTT assay, because the effect was supposed to be even clearer then. 
After treatment (Hypericin 1 µM, 18 min photoactivation), a high proportion of cells lost 
contact to the substrate. Cell shape changed to a more spherical appearance and intercellular 
space increased (Figure 4-16 B). Cells sometimes looked like they burst and were adsorbed 
strongly to the sensor surface. Enzymatic digestion of residual cell matter was necessary for 
cleaning sensors. 
On the other hand, no visually detectable destruction was evident for cells that were incubated 
with hypericin, but not irradiated. 
 
 
Impedance Spectroscopy and Model Parameters 
The effect of PDT was investigated by EIS on electrodes of 30 µm in diameter. Hypericin was 
applied at a concentration of 1 µM and irradiation lasted for 18 minutes.  
Impedance spectroscopy data is shown in Figure 4-17 in a Bode plot. During photoactivation, 
impedance magnitude decreased for frequencies above 400 Hz and impedance phase maximum 
shifted by a decade to lower frequencies. Compared to detachment assays presented in Figure 
4-4, these are similar characteristics.  
In Table 4-5 model parameter resistance R is compared with results of previously presented 
experiments. Sealing resistance R was reduced which corresponded to the visually perceivable 
formation of gaps between the cells.  
 
Figure 4-16: Effect 
of PDT monitored 
visually. Images of 
cells before (A) and 
after (B) photo-
activation. The 
shadow was cast by 
the microelectrode. 
B A 
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Table 4-5: Change of modelling parameter resistance R for PDT and other detachment assays on microelectrodes. 
The circuit used for interpretation of EIS data was shown in Figure 4-6. 
 
Experiment Type Change of Resistance SD Experiments 
Hypericin -0.433 0.28 7 
c(-RGDfV-) -0.374 0.50 8 
EDTA -0.703 0.25 3 
Trypsin -0.670 0.21 6 
Pipette flush -0.625 0.31 4 
 
 
 
 
 
Figure 4-17: Photodynamic Treatment investigated by EIS. Tumour cells were incubated with 1 µM hypericin. 
The impedance of an electrode (30 x 30 µm²) was measured before and after photoactivation. The experiment was 
performed at 37°C. 
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Dynamic Process of PDT Monitored by Impedance Analysis 
Again, cells were incubated with hypericin (1 µM) on a Flip-Chip sensor with integrated large 
electrodes (300 x 300 µm²) and monitored by EIS. First, the sensor system was kept in the dark 
and two curves were recorded in an interval of 30 minutes. These curves Base line and Start PA 
(photoactivation) showed that the system was in a steady state before PDT started. Then, 
impedance magnitude plots were recorded at an interval of 3 minutes and normalised to Start 
PA data.  
Superimposed spectra are depicted in Figure 4-18. After photoactivation started, impedance 
magnitude decreased, reached saturation after about 12 min, and, surprisingly increased again 
during the late course of the experiment. It will turn out that this response is characteristic for 
the photoactivation of electrodes immersed in hypericin and must not necessarily be a cellular 
response.  
The sensitivity maximum is located in the range of 16 kHz, which correlates to the results of the 
single frequency attachment experiment on a 300 µm electrode shown in Figure 4-11 B. The 
process of PDT was displayed as a single frequency representation at 16 kHz in Figure 4-19. 
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Figure 4-18: Impedance magnitude change of an 300 µm wide electrode during irradiation lasting for 22 minutes. 
Data was normalised to Start PA data. Base line was recorded 30 minutes before irradiation began and served as a 
control measurement. The experiment was performed at 37°C. 
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Figure 4-19: Single frequency impedance analysis of PDT. Impedance values were extracted from impedance spectra 
at 16 kHz on the data presented in Figure 4-18. 
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Single Frequency Impedance Sensing  
The effect of hypericin containing culture medium on a bare, cell-free gold electrode (300 x 300 
µm²) monitored by single frequency impedance sensing is shown in Figure 4-20. Irradiation of a 
gold electrode immersed in hypericin (1 µM) resulted in a reversible decrease of electrode 
impedance in the range of 100 Ω. 
 
 
 
 
 
 
 
 
 
 
 
Then, tumour cells (OV-MZ-6) were continuously monitored on a microelectrode (30 x 30 µm²) 
using the impedance sensing system, adjusted to a stimulation frequency of 95 kHz. It would 
have been interesting to perform these experiments also on the other electrode sizes, but 
unfortunately results are not available. Cells were incubated with hypericin (1 µM) and 
irradiated twice during a time period of 65 minutes. Despite the phases of photoactivation, the 
sensor was kept in the dark throughout the experiment.  
The impedance magnitude of the electrode is shown in Figure 4-21. Before the light treatment 
began, impedance magnitude was measured between 19.0 … 20.5 kΩ.  The slope of the 
impedance magnitude over time for the last 30 minutes before PA 1 was 0.04 kΩ / min. The 
first photoactivation interval (PA 1) lasted for about 7.5 minutes and induced a strong 
impedance magnitude decrease (slope: 0.21 kΩ / min). But interestingly, in contrast to the 
impedance sensing result, optical evaluation of the culture after PA 1 revealed no major changes 
in cell morphology. Most likely the duration of PA 1 was too short to result in sudden, visually 
detectable cell death. Impedance magnitude declined continuously even after termination of 
Figure 4-20: Impedance magnitude during photoactivation (using standard parameters).  
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PA 1 (slope: 0.13 kΩ / min) and did not reach saturation until the second photoactivation PA 2. 
Then, also micrographs documented visible destruction of the cells. 
Provided that the correlation “decrease of impedance magnitude” and “increase of intercellular 
space” is valid, cells were damaged in response to PA 1 and continued to degrade after the first 
activation finished. During PA 2 the degradation process ceased at the maximal effect. This 
experiment outcome shows that fixed frequency impedance sensing can visualise processes that 
are beyond the scope of optical microscopy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-21: Two-phase PDT monitored by single frequency impedance sensing.  
Stimulation frequency was set to 95 kHz. 
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4.2 Extracellular Recording from Cardiomyocytes 
This chapter describes the implementation of a cell-based sensing system that was used to 
extracellularly monitor electrical activity of cardiomyocytes in a microfluidic flow system. A 
robotic dispensing machine offered automated test substance application in microlitre scale. 
4.2.1 Set-up and Electrode Performance 
The fluid dispenser was located inside a laminar flow bench to ensure sterile working 
conditions, as shown in Figure 4-22. The sample holder (see also Chapter 3.3.2) was mounted 
on the working table of this device. The biosensor, the so-called microfluidic MEA chip (see 
Chapter 3.2.2), and the microfluidic chip (see Chapter 3.2.3) were positioned inside. For better 
visualisation it is recommended to view a short video documentation attached on CD-ROM (for 
a list of contents see Appendix F). 
 
 
 
 
 
 
The noise level of the electrode was in the similar range to the commercial sensors due to 
deposition of platinum black. Background noise was determined to about 2000 µV peak-to-peak 
(pp) were measured for uncoated gold electrodes in contrast to 20 – 100 µVpp amplitudes for 
coated electrodes. 
Figure 4-22: Setup used for extracellular recordings.
Sample housing 
Multi well plate 
Laminar flow bench 
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4.2.2 Cell Performance and Extracellular Recording 
Cell Viability and Electrical Activity  
Cellular activity of cardiomyocytes was investigated outside and inside the microfluidic system 
and compared to cells cultured on commercial available MEA devices. Sensors were covered 
with a confluent layer of cardiomyocytes (> 4 DIV) and signals were amplified against the 
counter electrode potential using the F-64 multichannel amplifier (Multichannel Systems, 
Reutlingen, Germany), described in Chapter 3.3.2. A peristaltic pump delivered culture medium 
at a constant, continuous flow rate of 0.4 µl/min. 
When seeded to MEA sensors, cardiomyocytes spontaneously generated action potentials and 
started to contract following a quiescent period of about 1–2 days. This electrical activity was 
highly synchronised throughout the complete culture. After insertion into the sample holder, 
cells at first showed a quiescent period of about 2 - 5 minutes, presumably due to the insertion 
process. On commercial MEA chips (no insertion necessary) sudden electrical activity was 
observed. But, after a while, spikes of both systems were quite similar in shape and amplitude. 
(Figure 4-23 A). Often, a positive peak was displayed as an initial spike component that is not 
directly attributed to the recorded myocyte. It represents the ionic return flow from surrounding 
tissue that was previously excited [Halbach 2003, Pottek 2006]. A sharp negative peak followed 
and sometimes a 100 – 300 ms lasting negative but more sustained component was visible. The 
sharp peak was presumably caused by the cell membrane depolarisation due to reflux of Na+ 
ions, while the following long-lasting Ca2+ influx into the cells was responsible for the second 
signal component. 
Within the fluidic system spike shape changed considerably during long-term operation. After 
10 to 30 minutes, most biosensor signals provided waveforms with decelerated time course as 
depicted in Figure 4-23 B.  
 
 
 
 
 
 
 
 
Figure 4-23: Electrical 
activity recorded from 
myocytes located within a 
microfluidic system. (A) 
Spike shortly after chip 
insertion. (B) Signal 
waveform from the same 
electrode 25 minutes later. 
A B 
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However, even with decrease of signal quality, the signal amplitude was still sufficient for a 
threshold-based spike detection. Cellular signals were detected for up to 6 hours inside the 
microfluidic system. A high synchronicity all over the sensor was observed as Figure 4-24 
documents.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-24: Synchronous cardiac myocyte signals. Screenshot of extracellular recordings on the microfluidic MEA 
chip. Axis show 2 Volts peak-to-peak over 2 seconds. The experiment was performed at 37°C. 
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4.2.3 Drug Screening 
Drug Responsiveness and Parameter Extraction from Recorded Signals 
Increasing concentrations of the β-adrenergic agonist isoproterenol in the range of 100 pM to 
100 nM were applied to the screening system. Spike rate and duration were investigated over a 
duration of about 50 minutes. Drug application was always followed by rinsing with standard 
culture medium. 
The time course of an experiment testing four isoproterenol concentrations is given in Figure 
4-25. After each isoproterenol application, a rinsing step followed that lasted until the initially 
monitored base activity was reached again. 
 
Figure 4-25: Rate measurements are shown over several concentration steps. Spike activity was given as the 
average rate calculated from intervals of 15 seconds. White areas indicated rinse cycles, whereas shaded 
areas refer to isoproterenol administration. Break down of electrical activity at 1 nM isoproterenol was due 
to air bubble transition. Base activity was in the range of 0.4 - 0.8 spikes per second [Pottek 2006]. The 
experiment was performed at 37°C. 
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After 24 minutes, during the second drug application phase (1 nM), air bubbles entered the 
fluidic system and caused transient activity reduction. Nevertheless, cardiomyocytes showed a 
strong effect to isoproterenol.  
 
 
 
 
 
 
 
 
Following drug application into the microfluidic system, the myocyte spike rate increased 
(Figure 4-26 A) and recovered during subsequent rinsing with pure culture medium. Signal 
acceleration was found to be dose-dependent. The system responded to an isoproterenol dose of 
about 100 pM and displayed saturation of the effect at 100 nM when spike rate was almost three 
times higher compared to the untreated condition (Figure 4-26 B). 
In addition, the spike waveform was sensitive to isoproterenol treatment. The time interval 
between the initial Na+ peak and the maximum of the repolarisation wave was decreased 
resulting in a shorter spike duration (Figure 4-27 B). This effect displayed dose-dependence 
with a threshold at 100 pM and a saturation at 100 nM isoproterenol. The interval was cut down 
to about 70 % of the original duration (Figure 4-27 A). Comparable values were also published 
by Jovanovic et al. [Jovanovic 2004].  
In comparison to extracellular recordings on commercial MEA sensors, both effects were 
observed to a similar extent (not shown). The increase of signal frequency may also be due to a 
larger Ca2+ transient resulting in an artefact in the double layer caused by increased frequency of 
contraction. To analyse this it might have been interesting to apply butadione monoxamine to 
the cardiomyocyte culture. This substance is known to uncouple contractile proteins from 
electrical activity. 
Figure 4-26: Isoproterenol administration to cardiomyocytes. (A) The spike rate was clearly improved upon 10 nM 
isoproterenol administration. (B) Increase of the mean spike rate due to isoproterenol administration at increasing 
concentrations [Pottek 2006]. 
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The robustness of this system was not satisfying. Cells were strongly impaired after at least 30 
minutes of operation which was too short to investigate substantial cell responses. The 
microfluidic chip was found to be part of this problem leading to a redesigned system using a 
step-like structure without direct streaming of medium across the cell culture. The existing 
device forced cell culture medium perpendicular to the cell culture surface (see Figure 3-6). 
Here, cells were directly confronted with streaming medium that although persistent adherence 
of cells requires shear stress free environment [Zantl 2004; personal communication]. 
Hence, the position of the microfluidic chip and the guidance of the channel were found to be 
central to impaired cell viability. Additionally, cells were located up-side-down on top of the 
Figure 4-27: Spike duration was investigated on microfluidic MEA chips. (A) Administration of isoproterenol 
resulted in a decreased spike duration, which was defined as the time interval between the initial fast spike 
component and the maximum of the slow depolarisation wave (K+ influx). (B) This effect was dose dependent 
[Pottek 2006]. 
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channel opening. This was part of the design concept, because the two openings, the injector 
port and the cell culture window, were etched into the silicon layer of the module and were 
therefore necessarily positioned in the same orientation. If air bubbles were transported inside 
the channel, they rushed across the cell culture with unfavourable effects for the cell culture. For 
instance, cells lost contact to the substrate and were rinsed off the sensor. 
Several attempts were performed to improve the existing system. The flow rate was decreased 
which in turn caused an increased evaporation of injected fluids and a longer duration of rinsing 
cycles. General experiences with microlitre volumes applied to open, unsealed systems imply 
that evaporation is a problem as long no vapour-saturated atmosphere exists. But, after flow rate 
reduction from 10 µl/min to 0.4 µl/min, cells adhered to the chip for a longer period of time. 
About 65 % of the sensor arrays showed spikes with unimpaired waveform (Figure 4-23 B), 
within the first 15 minutes. 
Spacers located on the MEA chip should prevent direct contact of streaming medium and cells. 
Therefore, PDMS spacers (thickness 0.2 to 0.9 mm) were placed between the MEA chip and the 
microfluidic chip. A hole, 1 mm in diameter, was mechanically punched into the spacer and 
aligned onto the cell culture. In practice, filling the spacers with culture medium was difficult, 
because air bubbles were trapped in the cavity of the spacer. Hence, cell viability was not 
improved by this method. 
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4.3 Microfluidic Cell-Based Sensor Platform 
Based on the experiences with cells in a microfluidic environment (Chapter 4.2), a new concept 
was realised. In detail, a microfluidic platform was capable of screening living cells by 
impedance spectroscopy, single frequency impedance sensing and extracellular recording. 
Using this device, pharmacologically relevant responses of the cells can be monitored and 
evaluated.  
Problems that arose using the previously described system were addressed with this new design. 
For instance, poor cell viability, evaporation of the injected fluid, and non-suitability for 
microscopy were identified as major disadvantages of the former system. 
4.3.1 Set-up 
In Figure 4-28 the sensor platform is shown with the peripheral instruments. Light source (Opto 
Sonderbedarf, Gräfelfing, Germany), temperature controller, and combined data acquisition and 
single frequency impedance sensing system were positioned on the left (top to bottom). The 
sensor holder was located in the central foreground. It was mounted on an X-Y table for moving 
the microscope focus across the cell sensor. Beneath the sample holder, multichannel amplifier 
and multiplexer board were mounted inside a aluminium box. The peristaltic pump for medium 
transport is shown in the centre background. The microscope objective and CCD camera were 
positioned above the measurement cell. 
 
 
 
Figure 4-28: Biosensor platform with peripheral devices.  
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4.3.2 Evaluation of the Screening System 
Cell Viability on Sensors 
Cardiomyocytes and human tumour (OV-MZ-6) cells were cultured on MEA sensors at a 
density of 400,000 cells per ml and stored in an incubator (37 °C, 5 % CO2 in O2). Micrographs 
of cardiomyocytes were taken during cell culture using the microscope system described in 
Chapter 3.3.3.  
Figure 4-29: Long-term observation of 
cardiomyocytes. The age of the culture is indicated 
on the left as days in vitro (DIV). The experiment 
was performed at 37°C. 
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After 2 days of culturing the cardiomyocytes a monolayer will have remodelled and cells 
showed initial contractions after 3 days in vitro (DIV). Cells often gathered in groups that 
showed persistent contraction. In Figure 4-29 images of cardiomyocytes between 5 and 11 DIV 
are depicted. Cells showed a high grade of contractile activity. 
The most critical procedure with respect to cell viability within the screening system was the 
sensor insertion at the beginning of each experiment. Because the sensor was immersed in a 
fluid during incubation, the peripheral contact pads on the MEA chip had to be dried before the 
sensor was inserted into the measurement system. During this step, culture chambers easily 
dried out or air bubbles were trapped inside the chamber (see next section). Nevertheless, most 
cell sensors showed electrical activity of a high quality for up to 8 hours. 
Evaluation of the Fluidic Chamber 
Throughout the experiments, sealing of the fluidic part against the MEA chip was identified as a 
difficult task. Air bubbles were easily trapped in the culture chambers between biosensor and lid 
and could not be removed even after fluid transport was started. The sealing was improved by a 
layer of Parafilm M (Brand, Wertheim, Germany) resulting in proper long-term water-tightness. 
Fluid injection was accomplished directly into the culture chambers because injection along the 
microchannel resulted in increased leakages. 
Focusing on the visual performance of cells inside the system, they were not strongly influenced 
by flowing medium (at a flow rate of 81 µl/min and a duration of 45 min). Experiments revealed 
that 10 µl per minute is sufficient for proper exchange of nutrition. A compilation of time lapse 
images of tumour cells cultured inside a fluidic chamber is enclosed in the Appendix 
(Chapter 7). 
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4.3.3 Impedance Analysis 
Impedance Spectroscopy of Tumour Cells on Various Electrode Types 
Impedance spectra of confluent grown tumour cells (OV-MZ-6) were monitored on various 
electrodes. Therefore, the electrode impedance was monitored prior to and after enzymatic 
removal of a confluent cell layer using 0.025 % Trypsin/EDTA (Sigma). Culture medium or 
Trypsin solution were continuously pumped through the chambers at a rate of 10 µl/min. 
Different electrode types were investigated simultaneously: Interdigitated electrode couples, 
microelectrodes (30 µm), and large electrodes (300 µm) which were all described in detail in 
Chapter 3.2.4.  
In Figure 4-30, impedance magnitude was analysed before and after cell detachment on the 
different electrode types. The values were normalised to the initial, cell-covered sensor and 
show that microelectrodes respond to cell coverage strongest - at least for frequencies around 
80 kHz. 
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Figure 4-30: Cell detachment on three different electrode types monitored by EIS. Impedance values were normalised 
to the cell covered state of the sensor. 
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Impedance Sensing of Tumour Cells 
The experiment described before was repeated with the single frequency impedance sensing 
system at a stimulation frequency of 95 kHz. 
In Figure 4-31, the impedance magnitude change during detachment is shown again for the 
three types of electrodes. Upon Trypsin application, a dead time of about 15 minutes was 
observed until cells detached. During detachment, impedance values declined sharply for 
approximately 10 minutes and reached saturation after 20 to 30 minutes. The decline resulted in 
a decrease of 2.5 kΩ for the large electrode, of 4.4 kΩ for the interdigitated electrode, and of 
7.8 kΩ for the microelectrode. Detachment was registered with the highest sensitivity by the 
microelectrode, which confirms previously presented results obtained by impedance 
spectroscopy.  
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Figure 4-31: Impedance sensing results of a detachment assay. Three different electrode types were screened at 
95 kHz during application of 0.025 % Trypsin. Data represent a single electrode each. 
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4.3.4 Extracellular Recordings 
Spiking activity of Cardiomyocytes 
Cardiomyocytes were seeded to culture chambers carrying microelectrodes. After an incubation 
period of 3 to 4 DIV sensors were placed into the sample holder and rinsed continuously with 
pre-warmed culture medium at a flow rate of 10 µl/min. Spiking activity was registered using 
the newly developed multi-channel filter amplifier and stored using the LabVIEW based 
application software. 
When inserted into the sample holder and rinsed, cells showed an improved viability compared 
to the previous system. Signal distortion, as described before during long-term monitoring in the 
previous sensing system (Figure 4-23), was not apparent anymore even for incubation periods 
of up to 6 hours. This leads to the conclusion that the cell-substrate contact remained intact 
throughout the experiment due to reduced shear stress. Visual observation of the culture 
chamber underpins this finding.  
The quality of extracellular recording (Figure 4-32) was found to be similar to the commercial 
system. In some cases, amplitudes exceeded values measured by the commercial system and the 
one presented in Chapter 4.2. The reason for this phenomenon is not clear – the gain factor of 
the multichannel amplifier was determined and implemented into the application software 
correctly. Crosstalk between the different (electrode) arrays was observed, which was 
diminished by setting the bandpass filter to appropriate values. 
 
 
 
Figure 4-32: Spikes recorded 
using the sensor platform.  
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Response to isoproterenol 
After a base activity was registered, isoproterenol was applied to cardiomyocytes at various 
concentrations from 10 pM to 1 µM. Chambers were rinsed with culture medium before the 
next drug concentration was applied. The spike rate of the cardiomyocytes during the first 15 
minutes including application of 10 pM isoproterenol is given in Figure 4-33. The base activity 
was already strong and registered as 1.2 - 1.5 s-1. The spike rate increased due to isoproterenol 
to a value of 2 spikes per second in average, partially reaching a spike rate of 3 s-1. Subsequent 
rinsing did not result in a recovery of the original activity. Isoproterenol concentrations of 
100 pM, 1 nM and 1 µM had similar effects on spike activity and are therefore not shown in 
detail. This result on the one side documents that the cell culture responded to the drug stimulus 
and, on the other hand, that the drug was not properly washed out after application. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-33: Effect of isoproterenol on spike rate of cardiomyocytes cultured in the sensor platform. Rate was 
averaged for a range of 15 seconds. Dashed lines represent intervals where no data points have been acquired. The 
experiment was performed at 37°C. 
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5 Conclusion and OutlookEquation Chapter (Next) Section 1 
5.1 Performance and Perspectives of the Sensor Platform  
Experiments that have been performed using the sensor platform in its final configuration 
proved its capability of measuring cell-substrate interaction by single frequency impedance 
sensing and electrical activity by extracellular recording. The key feature, providing a stable cell 
culture inside the fluidic system, was clearly improved over the previous attempts and allows 
monitoring of cells for hours without cell impairment now. The optical microscope and the 
16-channel multiplexer were important extensions of the existing systems, too. Interpreting 
cellular responses was much easier using simultaneous optical observation. 
Although a considerable effort was put into the generation of a novel system, problems 
concerning the microfluidic cell chamber were still apparent. A leakage between the PDMS 
layer and the cell chip corrupted the electrical sensing and air bubbles were trapped in the cell 
chambers. The leakage was successfully sealed by an additional layer of Parafilm M (Brand, 
Wertheim, Germany), but this caused a cleft of approximately 200 µm between silicon (sensor) 
and PDMS (lid). This had two major impacts: Both fluid streams (control and sample) were 
short-cut and a dead volume was generated above the silicon chip. The latter caused difficulties 
in dose-response measurements as pharmaceutical compounds were supposably not completely 
removed by rinsing phases. 
The employment of the two culture chambers was planned by co-culturing two different types 
of cells. Therefore, a cultivation protocol for harvesting hepatocytes from rat liver was being 
developed. Until the end of the project, establishing of the hepatocyte co-culture was not 
successfully achieved and the ‘final experiment’ was not accomplished. It was planned to apply 
the antidepressant amitriptyline (AT) to cardiomyocytes. AT is known to block sodium channels 
and therefore to decrease electrical activity [Ogata 1989]. AT is being transformed to inactive 
metabolised products by hepatic P450 enzymes [Cali 2005, Donato 2004]. When 
Cardiomyocytes are co-cultured with hepatocytes and are incubated with AT at micromolar 
concentrations, it is expected that initial electrical activity will be reduced. During the course of 
the experiment, hepatocytes mediate degradation of AT and therefore reduce the debilitating 
effect of the compound. This will, theoretically, result in increasing electrical activity. 
The biosensor platform is also well-suited to perform detoxification experiments using 
nanocapsules [Jovanovic 2004, Duran 2005]. Here, a compound that reduces electrical activity 
(e.g. AT) is applied to the circulating medium flow. Then, nanocapsules are introduced into the 
stream and the concentration of the compound is decreased as it is bound inside the capsule 
core. The detoxification kinetic profile can, theoretically, be analysed using the microfluidic 
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platform by monitoring the electrical activity. Impedimetric monitoring of the Hepatocyte 
culture might provide information about cell viability. 
As these examples show, the perspectives of the device are widespread. Analysis of cell-
substrate interaction (impedance electrode array) and electrical activity may be performed under 
microfluidic conditions allowing less compound consumption and easy implementation of 
automated substance application. Besides the described co-culture approach, the platform is 
suited to perform biocompatibility and shear-force assays using optical observation of the 
microfluidic chamber. It is also conceivable to realise a toxicity sensing system for e.g. 
contaminated drinking water. Schalie et al. described a battery of biosensing systems as 
promising for this purpose [Schalie 2006]. Among the systems that detected the most relevant 
chemicals in contaminated drinking water was electric cell impedance sensing. The extension 
by a system component monitoring electrical activity of neuronal networks allowed the 
detection of another substance. 
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5.2 Electrode Area has a Profound Influence on Electrode Impedance  
The investigation of the attachment of cells or bacteria on impedance based biosensors is an 
active field of research. It is well accepted that cell-spreading on electrodes leads to a reduced 
area on the electrode that is opposed to the electrolyte. Hence, electrode resistance is increased 
and electrode capacitance is decreased [Schwan 1963]. Analysis of the previously presented 
impedance results revealed that impedance magnitude increased by up to 170 % for a frequency 
that showed to be specific for the electrode size used. The frequency the sensor was most 
sensitive to cell-substrate interaction was found to be higher for small electrodes than for large 
ones (Figure 5-1). 
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Figure 5-1: Sensitivity of different electrode sizes to cell detachment  
 
This finding correlates to statements in publications that were compared for the sensitive 
frequency ranges (Table 5-1). Results were obtained for measuring MDCK-I epithelial cells on 
circular gold electrodes [Wegener 1996], suspensions of live and dead bacteria, Listeria 
innocua, on interdigitated electrodes [Gomez 2002], and 3T3 mouse fibroblasts and HCT116 
human cancer cells on an array of gold microelectrodes [Huang 2004]. 
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Table 5-1: Comparison of impedance results with other studies. flow and fhigh refer to frequency range that proved to be 
sensible to cell-substrate interaction. fmax refers to frequency of maximum impedance change. 
 
Apparently, the electrode size determines the sensitive frequency range. The low frequency end 
(flow) increases with rising electrode area, although Huang et al. report on results that do not fit 
into this statement. In principle, this is true also for the high frequency end (fhigh) and for the 
frequency of highest sensitivity fmax.  
Moreover, monitoring dynamic cell adhesion showed transition of the sensitivity maximum 
from high to low frequencies from 500 to 70 kHz for microelectrodes (A = 9 x 10-4 cm²). This 
was also confirmed for larger electrode sizes, e.g. 4 x 10-3 cm² [Huang 2004]. Hence, the result 
of single frequency impedance sensing of cell-substrate interaction is highly dependent on the 
frequency chosen for analysis. Cell attachment is first visible at high frequencies while 
disruption of cell monolayers can be first monitored at low frequencies.  
The type of cells investigated also plays a role for selecting electrode size and geometry. Cells 
that are able of building tight junctions were measured using large electrodes while leaky cell 
layers were measured using small electrodes [Wegener 1996]. In contrary to this statement, 
smaller electrodes investigated in this thesis responded with larger absolute resistance changes 
and therefore in a more sensitive way than large electrodes, although human ovarian cancer 
cells used in this thesis are also building tight junctions to each other [Reuning, personal 
communication]. 
The present project aimed to investigate the possibility of gaining information at a higher lateral 
resolution for MEA chips compared to large electrodes. It turned out that detection was limited 
by cell coverage and sealing resistance in general. If too few cells covered the electrode and 
large areas of unoccupied space was available, impedance data showed only slight changes.  
 Wegener 1996 Gomez 2002 Huang 2004 This work 
Ex-
periment 
Covered/uncovered 
sensors 
Live/dead cells in 
suspension 
Dynamic adhesion 
(duration: 5 hrs) 
Human ovarian cancer 
cells bare/cell covered  
Electrode 
area [cm²] 
4.5 x 10-1 4.6 x 10-3  4 x 10-3 9 x 10-4 9 x 10-6  
Type of 
electrode 
Circular gold 
electrodes 
Interdigitated 
electrodes 
Gold electrodes Gold 
electrodes 
 
flow  0.04 kHz 0.6 kHz 2 kHz 1 kHz 5 kHz 
fmax  0.6 kHz 20 kHz 20 kHz 10 kHz 100 
kHz 
fhigh 8 kHz 600 kHz --- 100 kHz 800 
kHz 
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5.3 The Capacitance and Resistance of a Cell Membrane 
Modelling EIS data of adherent human ovarian cancer cells by a constant phase element (CPE) 
in series with a resistor and capacitor in parallel proved to be a suiting model for the real-world 
situation. But, one has to bear in mind that the CPE is an empirically derived equation [Wegener 
1996] and that it is difficult to interpret its physical meaning. Attempts were performed to 
model EIS data by a capacitor/resistor couple in parallel but the fitting did not meet the 
measured data and due to this poor accuracy the usage of the CPE was preferred. 
Capacitances and resistances of cell membranes are often given as area-normalised values in 
literature. As an assumption of the capacitance serves the capacitance of a lipid bilayer that was 
found to be in the range of 0.5 µF cm-2 [Sackmann 1996] and therefore leads to an assumed 
capacitance of a cell membrane of 0.25 µFcm-2. Several publications investigating cells on 
impedance-based sensors are presented and compared to results of this work in Tables 5-3 and 
5-4. 
Table 5-2: Area-normalised modelling of cell covered sensors using a capacitor as electrode impedance. Equivalent 
circuits used for modelling were Celectrode – (Rcell layer//Ccell layer) – Rbulk [Wegener 1996, Hillebrandt 2001] and  
Rcell layer//Ccell layer [Ehret 1997] with “–“ counting for a series and “//” for a parallel connection. 
 Wegener 
1996 
Ehret 1997 Hillebrandt 
2001 
Electrode area 
[cm²] 
4.5 x 10-1 2.5 x 10-1 1.9 x 10-1 
Electrode type Circular gold 
electrodes 
Interdigitated 
electrodes 
Indium-tin-
oxide 
Cell type MDCK I LS 174T (like 
fibroblasts) 
HUVEC 
Celectrode [µF cm-2] 9.4 ± 1 --- 7.9  
Rbulk [Ω] 248 ± 2 --- 2500 
Rcell layer [Ωcm²] 112 ± 12 n/a 180 
Ccell layer [µFcm-2] 1.3 ± 0.2  0.080 0.1 
Measurements 8 1 1 
 
Table 5-3: Area-normalised modelling of cell covered sensors using a CPE as electrode impedance. Unit for the 
CPE-T parameter was derived from Fcm-2= Ω−1cm-2s. Cells used were bovine aortic endothelial cells [Wegener 1999] 
and OV-MZ-6. Equivalent circuits used for modelling were CPE – Rbulk – (Rcell layer//Ccell layer) [Wegener 1999] and 
CPE – (Rcell layer//Ccell layer) with “–“ counting for a series and “//” for a parallel connection. 
 Wegener 
1999 
This work 
(d=15µm) 
This work 
(d=30µm) 
This work 
(d=40µm) 
Electrode area [cm²] 2.5 x 10-1 2.3 x 10-6 9 x 10-6 1.5 x 10-5 
CPE-T [mΩ−1cm-2sα] 12400 0.6 ± 1.3 0.3 ± 1.3 0.036 ± 0.067  
Rbulk [Ω] 283 --- --- --- 
Rcell layer [Ωcm²] 5.1 0.07 ± 0.04 0.34 ± 0.25 0.33 ± 0.21 
Ccell layer [µFcm-2] 0.6 9.9 ± 1.67 5.35 ± 4.2 0.88 ± 0.34 
Measurements 1 3 7 3 
 
Electrodes that were compared with the ones used in this work are evidently larger and 
therefore, suspicions may be due to this fact. First, the capacitance of the cell layer was reported 
in the range that was assumed before. The smaller the investigated electrodes became, the 
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higher the capacitance was. Hence, area-normalisation may not be an appropriate method to 
work on electrodes smaller than 1 x 10-5 cm-2 and therefore, values were always presented in the 
results section as absolute values. 
Then, area normalised resistances showed to be smaller which might be due to the cell type that 
may not form very tight junctions as epithelial cells do. 
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7  Appendix 
A - Cell Culture 
7.1.1 Preparation of Media 
Abstract Media for the cultivation of cardiomyocytes and OV-MZ-6 are 
supplemented by various reagents 
Preparation Cardiomyocytes: 
(1) F-10 
(2) ITS 
(3) Pen/Strep 
OV-MZ-6 medium: 
(4) DMEM 
(5) Gentimycin 
(6) HEPES buffer 
(7) Arginin 
(8) Asparagine 
 
for both : 
(9) Foetal calf serum 
Instructions OV-MZ-6 medium: 
Add to 500 ml of medium (4): 50 ml serum (9), 2 ml (5), 1 ml amino acid 
solution (see below), 5 ml buffer (6). 
 
Prepare amino acid solution from (7) and (8): Let 1.16 g Arginine (7) and 
0.36 g Asparagine (8) dissolve in 20 ml MilliQ water. Pass solution 
through a 0.22 µm filter. 
Remarks: (4) 61965-026, Gibco 
(5) 15710-049, Gibco 
(6) 15630-056, Gibco 
(7) A-5131, Sigma 
(8) A-4159, Sigma 
(9) 10270-106, Gibco 
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7.1.2 Thawing Cells from Liquid Nitrogen 
Abstract Cryo-conserved OV-MZ-6 cells are transferred into culture medium for 
cultivation in incubator 
Preparation Cool down centrifuge to 4 °C 
Refrigerate at 4 °C: 
(1) OV-MZ-6 medium (see 7.1.1), 0 % FBS  
(2) OV-MZ-6 medium, 10 % FBS 
 
Place in water bath at 37 °C: 
(3) OV-MZ-6 medium, 0 % FBS 
(4) OV-MZ-6 medium, 10 % FBS 
Wear cryo-gloves and goggles. 
Instructions Take off cryo-tube from nitrogen tank and open it slightly (danger of 
explosion of a sealed tube). Clean outer surface with ethanol (70 %). 
Re-suspend cells with (1) and transfer all cells to test tube. Centrifuge 
(n = 1300 rpm, t = 5 min, T = 4 °C). Discard supernatant fraction and re-
suspend pellet with (3). Wash cells gently. Centrifuge (n = 1300 rpm, 
t = 5 min, T = 22 °C), discard supernatant, wash in (4), and place 
appropriate cell number into tissue flask. 
Remarks: (1-4) 10270-106, Gibco 
 
7.1.3 Freezing Cells 
Abstract Cell lines are stored for longer periods of time in liquid nitrogen 
Preparation Place in water bath at 37 °C: 
(1) Defreezing medium (10 % DMSO) and also 
PBS w/o Ca2+ and Mg2+ 
PBS with 0.025 % EDTA 
OV-MZ-6 medium with 10% FBS (according 7.1.4). 
Cryo-tubes, access to –70 °C freezer 
Instructions Follow preparation instruction 7.1.4 but re-suspend cells in the last step in 
(1). Prepare cell concentration of 5 million cells per ml avoiding air 
bubbles and place aliquots of 1ml into cryo-tubes. 
Place tubes in a rack and put them in the freezer (-20 °C) overnight. Next 
day place the rack into the –70 °C deep freezer. After 24 hrs the tubes can 
be placed in liquid nitrogen. 
Remarks: (1) 11101-011, Gibco 
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7.1.4 Passaging of OV-MZ-6 Cells 
Abstract Split cells and exchange used medium 
Preparation Place in water bath at 37 °C: 
(1) PBS w/o Ca2+ and Mg2+ 
(2) PBS with 0.05 % EDTA 
(3) OV-MZ-6 medium with 10 % FBS (see 7.1.1) 
(4) EDTA (1 % w/v) w/o Ca2+ and Mg2+ 
 
Prepare (2) of 19 ml (1) and 1 ml (4). 
Instructions Discard medium in tissue flasks and exchange against (1) to wash off 
loose cells and residual serum. 
Shake flask and replace (1) with (2). Place flask in the incubator for 
5 min or until cells are suspended. 
Transfer contents of flask in a test tube and centrifuge it (n = 1300 rpm, 
t = 3 min). 
Discard supernatant and re-suspend cells in 1 ml (3). Count cells 
according to standard procedure. Place 10,000 cells into new flask and 
add (3). Place flask back into incubator. 
Remarks (1) 14190-094, Gibco  
(4) L 2113, Biochrom  
 
7.1.5 Culturing Cardiomyocytes on Sensor Devices  
Abstract Cardiomyocytes already prepared as a cell suspension are incubated on 
sensor devices. 
Preparation (1) MilliQ water, sterile 
(2) Cardiomyocytes medium, 10 % serum, cooled 4 °C 
Place in water bath at 37 °C: 
(3) Cardiomyocytes medium, 10 % 
(4) Cardiomyocytes medium, 3 % 
Instructions Preparation of hearts results in a cell suspension. Count cells according to 
standard procedures. Add (2) to prepare a cell suspension of 8x106 cells 
per ml. Store on ice. 
Sensor preparation: Remove surplus fibronectin solution and rinse with 
(1) at least 3 times. Shortly after drying with nitrogen place 50 µl (Flip-
Chip MEA sensors) or 12.5 µl (microfluidic MEA sensors) on the 
sensitive area of the MEA chip. These volumes correspond to 400,000 
and 100,000 cells, respectively. Leave sensors in the incubator for 2-3 
hrs. 
Then apply (3) to the sensors carefully. 24 to 36 hrs later exchange 
medium against (4). Renew medium every 48 hrs using (4). 
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7.1.6 Hypericin Stock Solution 
Abstract Preparation of HY stock solution 
Preparation (1) DMSO 
(2) Hypericin, 1 mg 
(3) Syringe, 1 ml and needle 
(4) Eppendorf test tubes, 1.5 – 2 ml 
Instructions Hypericin is highly sensitive to illumination. Therefore, the equipment 
has to be wrapped in aluminium foil (2-4). 
Syringe (3) is filled with 1 ml of (1) and mixed with (2). Aliquots are 
placed in (4) and kept in the freezer at -20 °C. 
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7.2 B - MEA Sensors 
7.2.1 Cleaning Protocol after Experiment 
Abstract Cleaning sensors after experiment 
Preparation Place in water bath at 37 °C: 
(1) Trypsin 0.25 % 
Leave at room temperature: 
(2) BM detergent, 3 % 
(3) Ultrasonol 7, 2% 
Instructions To remove all cellular residues sensors are incubated in (1) for 10 min in 
water bath at 37 °C. 
Rinse sensors thoroughly in MilliQ water and apply (2) for 30 min. 
Rinse sensors thoroughly and apply (3) for 30 min. 
Rinse and dry in nitrogen. 
Remarks: (1) T4049, Sigma-Aldrich Chemicals 
(2) BM-flüssig, Biomed, Oberschleißheim, Germany  
(3) Carl Roth, Karlsruhe, Germany 
 
7.2.2 Sensor Preparation  
Abstract Preparation of sensors for EIS or extracellular recording experiments 
Preparation (1) BM detergent, 3 % 
(2) Ultrasonol 7, 2 % 
(3) PBS w/o Ca2+ and Mg2+ 
(4) aliquot of adhesion promoting protein (P) 
Instructions For surface activation with BM and subsequent neutralisation see  
Chapter 7.2.1.  
Desinfection with ethanol (70 %) for 10 min 
Rinsing and drying in nitrogen 
P (4) is applied on the sensor at concentration of 10 - 50 µg/ml in (3). AN 
amount of 50 – 100 µl is pipetted to the MEA hip, and the sensor is kept 
in the incubator for 2-6 hrs or in case of later cell addition is transferred 
to the fridge. 
Remarks: (1) BM-flüssig, Biomed, Oberschleißheim, Germany 
(2) Carl Roth, Karlsruhe, Germany 
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7.2.3 Platinising Solution 
Abstract Kohlrausch’s solution for platinum black deposition on MEA chips 
(7.2.4) 
Preparation (1) Hexachloroplatinum acid hydrate 
(2) Lead(II)citrate trihydrate 
(3) Agarose 
(4) Microwave oven 
Instructions Prepare solution A and solution B: 
Solution A 
1000 mg (1) and 50 mg (2). Add 100 ml MilliQ water. Keep (1) under 
Argon. Stir well when adding (2). 
Solution B: 
To 25 mg (3) add 100 ml MilliQ water. Let the polymer dissolve by 
heating up in a microwave oven. 
Place solutions A and B in a graduated flask and fill up to 250 ml with 
MilliQ water. Store solution in a dark glass bottle in the fridge. 
Remarks: Adapted from [Udin 1995] 
(1) Fluka 81080, Sigma-Aldrich Chemicals 
(2) Fluka 15326, Sigma-Aldrich Chemicals 
(3) Sigma A-4804, Sigma-Aldrich Chemicals 
 
 
 
 
7.2.4 Platinising 
Abstract Deposition of platinum black on microelectrodes to reduce electrode 
impedance 
Preparation (1) Power box, (cables), multimeter 
(2) Ultrasonic bath 
(3) Platinum rod (coiled), diameter 1 mm 
(4) Platinising solution according to Chapter 7.2.3 
(5) MEA chips with centralized galvanic contact 
Instructions Adjust (1) to appropriate values. For a whole wafer choose I = 2 A and  
E = 3 V.  
Connect galvanic contact (microelectrodes) to the negative output of 
power box (1). Connect the counter electrode (3) to the positive output. 
A beaker of (4) is placed into an ultrasonic bath (2). Put the MEA chips 
(5) and the counter electrode (3) into the platinising solution and start 
platinum deposition by switching on the power box under ultrasonic 
conditions. Control the deposition time with a stop watch. 
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7.3 C - Experiments 
7.3.1 Isoproterenol on Cardiomyocytes 
Abstract Schedule for extracellular recording of cardiomyocytes. Spike rate can be 
enhanced by isoproterenol 
Preparation (1) Cardiomyocytes on sensors, at least 2 DIV 
(2) Isoproterenol 
(3) Phase contrast microscope 
(4) Setup with microfluidic chip, amplifier, and DAQ 
Place in water bath at 37 °C: 
(5) Cardiomyocytes medium F-10 supplemented with ITS, Pen/Strep w/o 
FBS 
Instructions Evaluate contractions under microscope 
Prepare solution of (2) freshly each time. (5) is used to dilute stock 
solution. Keep samples in the water bath. 
After insertion to extracellular recording system: 
First a basal activity has to be determined. Ideally, this is represented by 
0.3 to 0.7 spikes per second. This activity shall be reached for each 
concentration step after rinsing. 
First medium without drug is first as a blind probe. As injection volume 
10 µl are sufficient. Then isoproterenol concentrations beginning with 10 
pM are applied followed by a rinsing cycle of at least 5 min. 
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7.3.2 Integrin Ligands on OV-MZ-6 Cells 
Abstract OV-MZ-6 cells are injected to the sensor at a certain stage of 
development (70-80 % confluence). Impedance spectroscopy is being 
performed on single microelectrodes monitoring the impact of integrin 
ligands on the cells. 
Preparation Place in water bath at 37 °C: 
(1) PBS w/o Ca2+ and Mg2+ 
(2) PBS with 0.025 % EDTA 
(3) OV-MZ-6 medium with 0 % FBS 
(4) Trypsin, 0.25 % 
 
(5) MilliQ water, sterile 
 
Instructions Cell preparation: Follow 7.1.4 until the last re-suspension step. For re-
suspension use (3) and determine cell concentration by counting cells 
using a NEUGEBAUER counting chamber.  
Sensor preparation: Use sensors with fibronectin coated surface (7.2.2). 
Remove surplus fibronectin solution and rinse with (5) for at least 3 
times. Dry in nitrogen and apply 1 ml of (3) onto culture dish. 
Record the impedance spectrum for an uncovered electrode, subsequently 
discard medium and inject 200 µl of the prepared cell suspension onto 
inner glass ring. Place the sensor in the incubator for at least 20 min 
before medium (3) is added to 1 ml and monolayer is formed. 
Record EIS spectrum for the cellular monolayer if no continuous 
measurement was chosen. 
Prepare c(-RGDfV-) and c(-RADfV-) solution at concentrations of 250 to 
500 µg/ml in (3) and exchange medium against RGD/RAD containing 
solution. Incubate systems for 2 hrs followed by EIS scans. 
After the effect of RGD/RAD has reached an equilibrium, discard 
medium, and place (2) or (4) onto sensor. Record another spectrum of the 
electrode after cells are removed from the sensor. 
Remarks: See Chapter 7.1.4 
 
7.3.3 Hypericin on OV-MZ-6 Cells 
Abstract OV-MZ-6 cells are supplied to the sensor at a certain stage of 
development (70-80 % confluence). Impedance spectroscopy is being 
performed on single microelectrodes monitoring the impact of hypericin 
on the cells in darkness and illumination, respectively. 
Preparation (1) Hypericin stock solution 
Instructions Follow procedure 7.3.2 until monolayer formation has been completed. 
Record the EIS spectrum for the electrodes covered with cells. 
(1) is diluted to the appropriate concentration and placed into the water 
bath at 37 °C until application onto the sensor. 
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To determine the effect on the cells in darkness, the sensor is wrapped in 
aluminium foil and placed into the incubator. For assessing the effect of 
illumination the foil is removed. 
Time protocol: 
Seed and incubate for 24 hrs 
Add hypericin  
Incubate in darkness for another 24 hrs 
Wash twice, add new medium and photoactivate 
 
 
7.3.4 Immunofluorescence with Anti-fibronectin 
Abstract Immunofluorescence detection of fibronectin bound to chip surface 
Preparation (1) Anti-fibronectin, FITC coupled, 
    stock 2 mg/ml, 20 µl volume (light sensitive) 
(2) Paraformaldehyde, 2 % 
(3) PBS, pH 7.4 
(4) Fluorescent Mounting Medium 
Instructions Fixation using (2) for 15 min at 4 °C. 
Three rinsing steps with (3) at room temperature. 
Apply (1) in 1:20 dilution with (3). Wrap in aluminium foil instantly and 
keep it in the fridge (4°C) over night. 
Three rinsing steps with (3) at room temperature. 
Mounting with (4). Store in darkness at 4 °C 
Remarks: Assess blind probes: Scratch a pattern in a fibronectin coated glass 
substrate. 
(1) DPC Biermann, Bad Nauheim, Germany 
(4) S3023: Dako Corporation 
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7.4  E - Calibration of the System for Single Frequency Impedance 
Analysis  
Because the output of the lock-in amplifier (voltage) is not linearly correlated to the impedance 
the systems needs to be calibrated. Therefore, resistors of different values were measured with 
the ECIS system, and data were modelled by the Boltzmann function according to 
equation (7-1) 
 ( )1/ 2
0
0/
1( )
1 x U k
yf x y
e −
−= ++  (7-1) 
where y0 is a bias voltage, U1/2 is the voltage after 50 % signal increase, and k is the slope.  
In Figure 7-1 data of the calibration described above are shown. Settings B to E refer to the gain 
factors of the lock-in amplifier that were adapted according to the electrode type investigated.  
 
 
 
 
 
 
 
 
 
 
Figure 7-1: Calibration data for four different sensitivity settings and Boltzmann fittings. (Parameters: High 
dynamic mode, S1=off, τ =4, θ=0°)  
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7.5 F - Contents of the CD-ROM 
 
Nanoplotter.mpg Video clip showing the microfluidic biosensor system using 
extracellular recording during a measurement cycle.  
 
CardiacMyocytes.exe 
 
Beating cardiomyocytes on a microelectrode 
Fluid.exe 
 
Observation of cardiomyocytes in the microfluidic chamber 
 
